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Abstract 
 
Nowadays, cardiovascular diseases are mainly treated by implantation of a 
metallic or polymeric mesh, called stent, which maintains the artery widely open. 
This technique shows very good clinical results, however, it exists non-negligible 
cases of in-stent restenosis (ISR) and late stent thrombosis (LST) during the first 
year after stent implantation. These complications are mainly due to a delayed 
recovery of the endothelium after stent implantation, which also involves smooth 
muscle cells (SMCs) over-proliferation and platelets aggregation. Stent surface 
modification to modulate a specific cell lineage response has not been 
comprehensively explored. In particular, surface nano-topography, 
biofunctionalization or chemical features may be applied to increase endothelial 
cells (ECs) adhesion and/or migration, and to control platelet agglomeration. 
The overall aim of this thesis was to obtain novel modified surfaces for stents 
implants with the ability to induce accelerated reendothelialization and controlled 
platelet aggregation in order to avoid ISR and LST. On CoCr alloy, as the gold 
standard material for bare metal stents (BMSs), two different strategies were 
evaluated, generation of linear patterns by direct laser interference patterning 
(DLIP) and, immobilization of biomolecules. On poly(L-lactic acid) (PLLA), as a 
material for bioresorbable stents (BRSs), endothelialization was enhanced by 
surface functionalization with NaOH etching, plasma treatment and cutinase 
enzyme hydrolysis. 
CoCr alloy surfaces were successfully modified with a linear pattern of different 
periodicities and depths. Afterwards, Arg-Gly-Asp (RGD) and 
Tyr-Ile-Gly-Ser-Arg (YIGSR) peptides were covalently immobilized to the 
surfaces through silanization. Early ECs adhesion was improved on the 
peptide-functionalized surfaces, especially for YIGSR compared to RGD. 
High-depth nano-patterned surfaces generated ECs alignment within the 
topographical lines and enhanced ECs migration. Noteworthy, the combined use 
of both strategies, topography and biofunctionalization, synergistically 
accelerated the ECs migration and proliferation. Also, platelet adhesion and 
aggregation decreased in all patterned surfaces compared to smooth CoCr 
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probably due to changes in wettability and oxide layer characteristics. Cellular 
studies provided evidence of the potential of DLIP topographies and YIGSR 
biofunctionalization to foster endothelialization without enhancement of platelet 
adhesion, which will be of high importance when designing new stents. 
Concerning polymeric biodegradable materials, PLLA films were obtained by 
solvent-casting in chloroform and, oxygen plasma, NaOH solution or cutinase 
enzyme treatments were used to functionalize the PLLA films and create surface 
hydroxyl and carboxyl groups without compromising biocompatibility. A higher 
amount of functional groups and an improved ECs adhesion was observed by 
oxygen plasma and cutinase enzyme hydrolysis compared to NaOH etching. 
Plasma or cutinase enzyme functionalized PLLA films presented a degradation 
rate similar to a peripheral commercial stent. Finally, 3D-printed PLLA BRSs were 
obtained by solvent-cast direct write technique. Consequently, the combined use 
of the solvent-cast direct write technique and plasma or enzyme functionalization 
holds a great potential to fabricate 3D-printed PLLA BRSs with the capacity to 
accelerate the surface endothelialization. 
Overall, the present thesis offers a comprehensive view of the effectiveness of 
modifying CoCr alloys and PLLA films with specific topographies or 
functionalization strategies to enhance surface endothelialization while 
preventing restenosis and thrombosis.  
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Zusammenfassung 
 
Heutzutage werden vaskuläre Erkrankungen hauptsächlich durch Implantation 
eines metallischen oder polymeren Netzes, genannt Stent, behandelt, welcher 
vormals verengte Arterien weit geöffnet hält. Diese Technik zeigt bereits sehr 
gute klinische Ergebnisse. Allerdings existieren auch nicht zu vernachlässigende 
Fälle von In-Stent Restenose (ISR) und späten Stentthrombosen (LST) im ersten 
Jahr nach Implantation des Stents. Diese Komplikationen entstehen 
hauptsächlich aufgrund einer verzögerten Erholung der Endothele nach 
Einsetzen des Stents, sowie durch übermäßiges Wachstums der vaskulären 
glatten Muskelzellen (SMCs) und einer Thrombozytenaggregation. 
Modifikationen der Stent-Oberfläche, um die Interaktion mit spezifischen Zellypen 
zu kontrollieren, sind noch nicht umfassend erforscht. Insbesondere können 
Oberflächen-Nano-Topographie, Biofunktionalisierung oder chemische 
Modifizierungen angewendet werden, um die Adhäsion und / oder Migration der 
Endothelzellen (ECs) zu erhöhen und die Agglomeration von Blutplättchen 
niedrig zu halten.  
Das Gesamtziel dieser Arbeit war es, neuartige modifizierte Oberflächen für 
Stentimplantate zu entwickeln, die die Reendothelialisierung beschleunigen und 
eine Thrombozytenaggregation verringern, um ISR und LST vorzubeugen. Auf 
einer CoCr-Legierung, dem Gold-Standard-Material für unbeschichtete 
Metallstents (BMSs), wurden zwei unterschiedliche Strategien verfolgt; einerseits 
die Erzeugung linearer Muster durch direkte Laserinterferenzstrukturierung 
(DLIP) und Immobilisierung von Biomolekülen. Auf Poly (L-Milchsäure) (PLLA) 
als Material für bioresorbierbare Stents (BRSs) wurde die Endothelialisierung 
durch Oberflächenfunktionalisierung mit NaOH-Ätzen, mit einer 
Plasmabehandlung und mit Cutinase-Enzym-Hydrolyse verbessert.  
Zum anderen wurden Oberflächen einer CoCr-Legierung erfolgreich mit einem 
Linien-Muster unterschiedlicher Periodizität und Tiefe modifiziert. Anschließend 
wurden Arg-Gly-Asp (RGD) und Tyr-lle-Gly-Ser-Arg (YIGSR) Peptide durch 
Silanisierung kovalent an den Oberflächen immobilisiert. Die frühe ECs-Adhäsion 
wurde auf den Peptid-funktionalisierten Oberflächen verbessert, insbesondere 
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für YIGSR im Vergleich zu RGD. Nanostrukturierte Oberflächen mit großer Tiefe 
erzeugten eine ECs-Ausrichtung innerhalb der topographischen Linien und 
förderten die EC-Migration und -Proliferation. Bemerkenswerterweise wurden 
diese synergetisch durch Kombination der zwei Strategien, Topographie und 
Biofunktionalisierung, beschleunigt. Auch die Thrombozytenadhäsion und –
aggregation sanken in allen strukturierten Oberflächen verglichen mit glattem 
CoCr, möglicherweise auf Grund von Veränderungen der Benetzbarkeit und der 
Oxidschichteigenschaften. Zellstudien belegen das Potential von DLIP-
Topographien und YIGSR-Biofunktionalisierung, um die Endothelialisierung 
ohne Erhöhung der Thrombozytenadhäsion zu fördern, was von großer 
Bedeutung bei der Entwicklung neuer Stents sein wird.  
In Bezug auf polymere biologisch abbaubaren Materialien wurden PLLA-
Schichten durch Solvent-Casting in Chloroform hergestellt. Sauerstoffplasma, 
NaOh-Lösemittel oder Cutinase-Enzym-Behandlungen wurden genutzt, um die 
PLLA-Schichten zu funktionalisieren und Oberflächen-Hydroxylgruppen und -
Carboxylgruppen herzustellen, ohne die Biokompatibilität zu beeinträchtigen. Im 
Vergleich zu NaOH-Ätzen wurden durch Sauerstoffplasma und durch Cutinase-
Enzym-Hydrolyse eine höhere Anzahl an funktionellen Gruppen und eine 
verbesserte ECs-Adhäsion festgestellt. Plasma- oder Cutinase-Enzym-
funktionalisierte PLLA-Schichten zeigten eine ähnliche Degradation wie ein 
peripher, kommerzieller Stent. Abschließend wurden 3D-gedruckte PLLA-BRSs 
durch Solvent-Cast Direct Writing hergestellt. Folglich bietet die Kombination aus 
Solvent-Cast Direct Writing und Plasma- oder Enzymfunktionalisierung ein 
großes Potenzial, 3D-gedruckte PLLA-BRSs mit beschleunigter 
Oberflächenendothelialisierung herzustellen.  
Insgesamt bietet die vorliegende Arbeit einen umfassenden Überblick über die 
Effektivität der Modifizierung von CoCr-Legierung und PLLA-Filmen mit 
spezifischen Topographien oder Funktionalisierungsstrategien zur Verbesserung 
der Oberflächenendothelialisierung bei gleichzeitiger Vermeidung von 
Restenose und Thrombose. 
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Resumen 
 
Actualmente las enfermedades cardiovasculares están principalmente tratadas 
por implantación de una malla metálica o polimérica, llamada stent, que mantiene 
la arteria abierta. Esta técnica presenta muy buenos resultados clínicos, sin 
embargo, existen casos de reestenosis intra-stent (ISR) y trombosis tardia del 
stent (LST) durante el año que sigue la implantación. Estas complicaciones están 
principalmente debidas a una reparación demasiado lenta del endotelio después 
de la implantación del stent; que también implica una sobre-proliferación de 
células musculares lisas y una agregación de plaquetas. La modificación de la 
superficie del stent para generar una respuesta celular específica no ha sido 
explorada en profundidad. Particularmente, nano-topografía, biofuncionalización 
o modificaciones químicas pueden ser aplicadas para incrementar la adhesión y 
la migración de las células endoteliales (ECs), y para controlar la aglomeración 
de las plaquetas. 
El objetivo global de esta tesis es de obtener nuevas superficies modificadas 
para stent implantes con la habilidad de inducir una endotelización acelerada y 
de controlar la agregación de plaquetas. Sobre CoCr, material de referencia para 
los stent metálicos desnudos (BMSs), dos estrategias diferentes fueron 
evaluadas, la creación de patrones lineales por la técnica Direct Laser 
Interference Patterning (DLIP) y, la inmovilización de biomoléculas. Sobre acido 
L-poliláctico (PLLA), como material para stent biodegradables (BRSs), la 
endotelización fue activada por funcionalización de la superficie vía tratamientos 
con NaOH, plasma o enzima cutinasa. 
Patrones lineales de diferentes periodicidades y profundidades fueron obtenidos 
sobre superficies de CoCr. Después, los péptidos Arg-Gly-Asp (RGD) y 
Tyr-Ile-Gly-Ser-Arg (YIGSR) fueron enganchados covalentemente por 
silanización sobre les superficies de CoCr lisas y con patrones. La adhesión de 
ECs aumento sobre las superficies funcionalizadas, especialmente con el 
péptido YIGSR comparado con el RGD. Las superficies con patrones profundos 
generaron un alineamiento de las ECs con la dirección de las líneas del patrón y 
aceleraron la migración de esas mismas células. Además, el uso combinado de 
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esas dos estrategias, topografía y biofuncionalización, acelero sinérgicamente la 
migración y la proliferación de las ECs. Por fin, la adhesión y la agregación de 
plaquetas disminuyo sobre todas las superficies con patrones comparado con 
las superficies de CoCr lisas, efecto causado por los cambios de la capa de óxido 
introducido por la técnica DLIP. Los estudios celulares demuestran el potencial 
de las topografías DLIP y de la biofuncionalización para mejorar la endotelización 
sin aumentar la adhesión de plaquetas, lo que puede ser interesante a la hora 
de diseñar nuevos stents. 
En cuanto a los stent biodegradables, películas de PLLA fueron obtenidas por la 
técnica de solvent-casting y, plasma de oxígeno, solución de NaOH o enzima 
cutinasa fueron utilizados para funcionalizar esas películas de PLLA y, así crear 
grupos hidroxilos y carboxilos en superficie sin comprometer la 
biocompatibilidad. Plasma de oxígeno y enzyma cutinasa generaron más grupos 
funcionales y mejoraron más la adhesión de ECs comparado con el tratamiento 
de NaOH. Además, las superficies de PLLA modificadas por plasma o enzima 
presentaron una degradación similar a la degradación de un stent comercial. 
Finalmente, BRSs de PLLA fueron obtenidos por impresión 3D vía la técnica de 
solvent-cast direct write. Consecuentemente, el uso combinado de esa técnica y 
de la funcionalización por plasma o enzima presenta un gran potencial para 
fabricar BRSs de PLLA impreso en 3D con la capacidad de acelerar la 
endotelización de la superficie. 
En conclusión, esta tesis demuestra la efectividad de modificar las superficies de 
CoCr o PLLA con topografías específicas o con estrategias de funcionalización 
para mejorar la endotelización y paralelamente reducir los riesgos de trombosis 
y reestenosis.   
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Chapter I: Introduction  
 
 
Cardiovascular diseases is one of the leading causes of mortality and morbidity 
in the world 1. According to the World Health Organization (WHO), 17.3 million 
people died from cardiovascular related diseases in 2008, and this number is 
projected to rise to an estimated 23.6 million by 2030 2. Age and bad habits like 
smoking, sedentary lifestyles, or fat diet are a major factor in cardiovascular 
problems.  
Cardiac events like heart attack or cerebrovascular accidents are mainly caused 
by the formation of an artherosclerotic plaque in the artery wall which eventually 
blocks the blood flow preventing the delivery of oxygen and nutrients to the body. 
The main cardiovascular disease is atherosclerosis, which consists in an 
accumulation of lipids and cholesterol in the artery wall leading to a reduction of 
the artery inner section, also called stenosis. The evolution and rupture of the 
atherosclerotic plaque and the endothelium leads to the formation of thrombus, 
also called thrombosis.  
Nowadays, cardiovascular diseases are mainly treated by implantation of a 
metallic or polymeric mesh, called stent, which maintains the artery widely open 3. 
This technique shows very good clinical results however, it exists non-negligible 
cases of in-stent restenosis (ISR) and late stent thrombosis (LST) during the first 
year after stent implantation 4. These complications are mainly due to a delayed 
endothelium reconstruction after removal of the endothelium during stent 
implantation which also involves SMC over-proliferation and a platelet 
aggregation. The cardiovascular research is focused in improving stents by 
optimizing stent characteristics: design, material, drug delivery, surface 
coatings… However, few studies have been done on stent surface modification 
in order to modulate a specific cell lineage response.  
The overall aim of this thesis was to obtain novel modified surfaces for stents 
implants with the ability to induce accelerated reendothelization and controlled 
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platelet aggregation in order to avoid ISR and LST. In the present introduction, 
the scientific context is explained, as well as the medical problem, the stent 
solution, the stent biomaterials and the possible surface modifications to reach 
the presented aim. 
 
1. Endothelialization 
1.1. Definition 
Endothelialization is the formation of endothelial tissue. A healthy endothelium, 
the inner layer of the artery in contact with blood, is composed of a monolayer of 
endothelial cells (ECs) and it has antithrombogenic properties, among others. 
Consequently, endothelialization is an extremely important process expected to 
occur as soon as possible when the endothelium is damaged. 
1.2. Artery structure 
Arteries are blood vessels that carry oxygenated blood away from the heart to 
supply the body with oxygen. The native artery is an extremely complex 
multi-layered tissue composed of many proteins and cell types, each playing a 
crucial role in the mechanical and biological behavior of the structure. An artery 
is composed of three major layers as seen on Figure I.1:  
• Tunica intima or Endothelium, is the innermost layer of the vessel wall 
and it contains elastic and connective tissue. A monolayer of endothelial 
cells is in contact with the hollow internal cavity in which the blood flows, 
the lumen. As the cellular interface between the circulating blood and the 
vessel wall, the endothelium main function is to avoid blood coagulation 
through the production of molecules with antithrombotic properties, 
including nitric oxide, prostacyclin, tissue plasminogen activator, 
thrombomodulin, heparin-like molecules, and tissue factor pathway 
inhibitor 5. Moreover, the healthy endothelium permeability is also crucial 
to provide a barrier between the artery lumen and surrounding tissue, to 
keep the blood inside the artery and, at the same time, allows the 
exchange of nutrients with the interior of the tunica media 6,7. 
• Tunica media, is composed of elastic tissue and several layers of smooth 
muscle cells (SMCs) in a matrix of collagen types I and III, elastin and 
proteoglycans. In the largest arteries, as the aorta, the amount of elastic 
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tissue is very considerable. The muscle fiber cells are arranged in 5 to 
7 layers of circular and longitudinal SMCs of about 50 μm length 8,9. 
• Tunica adventitia or Tunica externa, is the most external layer 
composed of connective tissue with fibroblasts, microvascular networks 
and randomly arranged collagen type I 10,11. 
 
 
Figure I.1: Schematic views of the functional artery with its three major layers: endothelium, 
tunica media and tunica externa. 
 
1.3. Cardiovascular diseases 
Cardiovascular diseases are mostly caused by atherosclerosis, which is a 
physiologic phenomenon beginning at the embryonic stage and evolving with 
arteries ageing. This disease is related to genetic predisposition and lifestyle.  
Adhesion of circulating monocytes to the surface of the endothelium appears to 
be an early event in the development of atherosclerotic lesions. Next, they 
insinuate through the endothelium and are transformed into macrophages, which 
ingest lipids and form fatty deposits 12. Meanwhile, a number of molecular factors, 
like platelet adhesion, generate proliferation of SMCs in the intima. Monocytes, 
lipids, platelets, SMCs, and fibrous connective tissues form an inflammatory 
plaque called atheroma (Figure I.2). Finally, atherosclerosis can generate two 
main complications: 
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 Stenosis, which is the long-term evolution of atherosclerosis due to a slow 
growth of the atheroma plaque leading to final obstruction of the artery. 
 Thrombosis, which is a quick and acute complication corresponding to the 
rupture of the endothelium and/or the atheroma plaque. This rupture exposes 
the collagen of tunica intima connective tissues to the bloodstream 13. On 
contact with collagen, platelets become activated. Platelet activation induce 
several thrombogenic event like platelet adhesion and aggregation 14. Finally, 
a thrombus is formed which can obstruct the artery or detach and obstruct 
another vessel. 
 
Figure I.2: Schematic representation of a portion of artery in a healthy state, with atherosclerosis 
disease progress at different stages, resulting in stenosis and/or thrombosis. 
 
1.4. Stents 
In the 70’ coronary diseases were healed by Coronary Bypass Graft Surgery 
consisting in removing the occluded section of the artery and replacing it with a 
healthy conduct by performing a coronary bypass. But this open chest surgery is 
an invasive method which is therefore heavy and complicated. Also, as it requires 
the chest wall to be cracked open, it can easily lead to infections. 
The advent of percutaneous transluminal coronary angioplasty in 1977 
provided a fundamental change in the treatment of coronary artery diseases 1. 
Angioplasty is the technique of mechanically widening narrowed or obstructed 
arteries. Percutaneous surgery, also called “non-invasive” surgery means that 
the surgery is done through the skin instead of doing open chest surgery. It 
consists in doing a small incision in the patient’s skin at the level of an artery. 
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Then a catheter is inserted through the incision in the vascular system. These 
catheters are hollow flexible tubes for insertion into a body vessel to distend a 
passageway for other medical tools. Unlike the traditional open heart surgery, the 
heart does not need to be arrested during the procedure. 
Non-invasive surgery has been used since 40 years with the first human coronary 
balloon angioplasty performed intra-operatively in 1977 by Gruentzig, Myler and 
Hanna in San Francisco 1. It consisted in the enlargement of the stenosed 
coronary artery thanks to a balloon inflated in the atherosclerosed artery 
portion (Figure I.3). 
Rapidly the coronary balloon angioplasty will be replaced by the use of coronary 
stent. Stent are mesh implanted in the diseased arteries to hold it open to a 
predetermined diameter (Figure I.3). In 1982, appeared the first patent, by Hans 
Wallsten, concerning a self-expandable metallic braided stent called Wallstent 
(Boston Scientific, United States) 15. The first implantation of the Wallstent in 
human coronary position is done by J. Puel in 1986 15.  
 
Figure I.3: Non-invasive coronary surgery on a stenosed artery: angioplasty on the left and stent 
implantation on the right. 
 
Vascular stents represent today one of the main application of percutaneous 
technology. Its popularity arises due to its less invasive nature (compared to 
surgical alternatives) and its better clinical outcome (compared to balloon 
angioplasty) 16,17. The use of stents for all applications has dramatically increased 
Chapter I: Introduction  
6  
 
since their approval by the United States Food and Drug Administration (FDA) in 
1994, largely as a result of therapeutic and technological advances. In 2010, in 
the United States, an estimated of 492 000 patients underwent percutaneous 
transluminal coronary angioplasty in the United States and the stent market reach 
$5 billion per year 18. 
 
1.4.1. Stent properties 
Endovascular stents are expandable meshes that range from 6 to 60 mm in 
length and from 2 to 10 mm in diameter, most commonly made from stainless 
steel, chromium-cobalt alloy,  the nickel-titanium alloy Nitinol, although tantalum 
19, platinum 19, plastic 20, and biodegradable materials 21,22 have also been  used. 
In a compressed state the stent is mounted on a catheter and threaded through 
the vascular tree to a site of narrowing. The stent is next enlarged in diameter 
approximately 50%, either by a spring-like recoil into their naturally expanded 
shape (e.g. Nitinol) or by plastic deformation under the influence of a cylindrical 
balloon inflated within the stent to 8-20 atmospheres of pressure. Once the 
catheter is withdrawn the stent is left within the artery. 
As the stent’s main function is to compress the atheroma, stent should present 
high mechanical properties as high Young’s modulus (E) or high ultimate tensile 
strength (UTS) (Table I.1). As for all implant, stent materials should be 
biocompatible and corrosion resistant in body conditions. 
Table I.1: Stent required characteristics and associated biomaterials properties. E: Young 
modulus; UTS: Ultimate tensile strength 
Stent necessary 
properties  
Description 
Associated 
biomaterials properties 
High scaffolding 
Ability to provide strong mechanical support 
to the vessel wall 
High E 
High expansion ratio 
The material should undergo sufficient 
expansion and conform to the vessel wall 
High UTS 
Excellent corrosion 
resistance 
Ability to prevent corrosion induced by 
formation of oxide films 
No prejudicial corrosion in body 
conditions 
Good 
biocompatibility 
Material must be biocompatible so as to not 
elicit an adverse reaction from the body 
Low % of complications in the 
clinical studies  
Thrombo-resistivity 
The material should be blood compatible 
and not encourage platelet adhesion and 
deposition 
Low % of thrombosis in the 
clinical studies  
Inexpensive to 
manufacture 
The material should be cost-effective to 
purchase 
Cheap and easy-to process 
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1.4.2. Stent evolution 
1.4.2.1. Bare metal stent (BMS) 
BMS, which is an expandable tube of metallic mesh, was introduced in 1986. 
BMS provides a mechanical scaffold to widely open the narrowed artery, to 
prevent artery elastic recoil and negative remodeling. However, besides crushing 
the atheroma plaque, stent deployment destroys partially and disrupts the 
endothelium 23, triggering an over-exposure of collagen, SMCs, fibronectin and 
laminin to the blood flow; and consequently generating a cascade of 
thrombogenic events allowing the platelets to aggregate. This is the initial point 
of the thrombus formation, creating a wall injury that presents clot formation 
where the macrophages get attracted due to the metallic foreign surface. Finally, 
it occurs an uncontrolled proliferation and migration of SMCs to the intima leading 
to the re-narrowing of arteries called in-stent restenosis (ISR) 19,24,25. As a 
consequence of this cascade of biological events, it can be observed early 
thrombosis, 1 to 3 % the 10 first days 15 and mostly ISR during the first year after 
stent implantation 3 (Figure I.4). However, when compared with balloon 
angioplasty, BMS significantly reduces the ISR rate from 50 % 
to 20 – 30 % 3,16,21.  
1.4.2.2. Drug Eluting Stent (DES) 
In addition to acting as a vascular scaffold, stents soon evolved to become drug 
delivery systems in the form of DES. DESs are composed of a metallic stent 
covered by a polymer which contains a pharmacologic agent. They allow a local 
drug release to the artery wall. These drugs include anti-inflammatory, 
anti-proliferative and anti-migratory agents. The goal of DES technology is to 
minimize vascular inflammation and SMCs proliferation, in order to reduce ISR. 
Early trials of different DESs demonstrated markedly reduced rates of ISR from 
20 – 30 % to 5 – 10 % 26–29, heralding the DES revolution that followed. Although 
DESs reduce ISR, the liberation of anti-proliferative drugs also induce a delayed 
reendothelialization and, consequently, increased the risk of LST occurring more 
than one year after stent implantation 30–32. Some studies, identified a rate of late 
stent thrombosis (LST) as high as 9.4% 33. Consequently, continuation of 
dual-anti-platelet therapy is required for one or more years after DES placement. 
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1.4.2.3. Bioresorbable Stent (BRS) 
The interest of a BRS is to have a temporary stent that bioabsorbs with time 
allowing the vessel to recover its natural shape and function. BRS are an 
alternative for the currently-used permanent cardiovascular stents as it has been 
shown that the effect of stents is temporary and limited to a period of 6 to 12 
months after intervention during which arterial remodeling and healing occur 34. 
The advantages of BRS in front of DES are the stent fully degradation in 12 to 24 
months, among others: 
 A reduction in adverse events such as LST 35,36. 
 The return of vessel vasomotion, adaptive shear stress, late luminal 
enlargement, and late expansive remodeling 37. 
 A reduction in bleeding complications and consequently no requirement 
for long-term dual antiplatelet therapy. 
 Elimination of the concern that some patients have of having an implant in 
their bodies for the rest of their lives 38. 
It’s worth mentioning that actual research on BRS is developing stents with a 
polymeric coating containing pharmacologic agents.  
 
Figure I.4: Complications after stent implantation. (a) Section of artery just after stent 
implantation. (b) ISR due to stent implantation. (c) Different stages of stent thrombosis. 
 
1.4.3. Stent next generation 
BMS, DES and BRS main characteristics are summarized in Figure I.5. Fully 
biodegradable stent seems to be the ideal compromise to, first, induce the artery 
to recover its structure and functionality and, secondly, to avoid ISR or LST 
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generated by the presence of permanent BMS or DES. However, BRS are very 
new devices and the Food and Drug Administration (FDA) waited to July 2016 to 
approve the first BRS for coronary artery, the Absorb GT1 (Abbott, 
United States). At April 2017 Abbot restricted the use of Absorb GT1 in Europe 
due to some cardiac events related to the implantation of this BRS. Moreover, in 
tortuous section of the artery, there is higher mechanical stress due to blood flow 
modification. In these portions of arteries it would be risky to use BRS due to its 
mechanical properties deterioration with biodegradation. Thus, permanent stent 
will continue being implanted for several years or decades. Generally, BMSs 
have a higher incidence of ISR whereas DESs have a higher frequency of LST. 
Then, the surgeon select one of the two according to the cardiovascular disease 
specificity. In conclusion, we believe that in the short and medium term no one 
will be discarded, stent implantation will be done with BMS, DES or BRS 
according to the medical cases. 
 
Figure I.5: Stent generations and its mains characteristics. Modified from 39. 
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2. Biomaterials for stents 
2.1. Cobalt-chromium (CoCr) alloy for stents fabrication 
2.1.1. Metals for stents 
As the main objective of the BMS was to counter the negative effects of the 
balloon angioplasty, it should address properties such as rigidity for maintenance 
of dilatation and resistance to elastic recoil, elasticity or plasticity for expansion, 
corrosion resistance, radiopacity and radial strength 15.  
Therefore, from the viewpoint of mechanical properties, it is natural that stents 
are made of metals. The metallic materials most currently used for coronary 
stents are 316L stainless steel (SS), cobalt chromium (CoCr) alloys and 
titanium alloys 40–42. 
Stainless Steel 
SS is a steel alloy with a minimum of 12-13 mass % of Cr. The main reason for 
the use of SSs is the good balance between strength (E ≈ 193 GPa) and 
elongation, which facilitates the manufacture of the stent, the plasticity for the 
balloon expansion, and the maintenance of geometry to resist the elastic recoil 
of blood vessels. Most metal stents are made of austenitic SS 316L. SSs do not 
corrode in an oxygen-containing atmosphere, but they corrode locally and 
sometimes form pits in chloride solutions as found in some body fluids. Type 
316L SS shows pitting and crevice corrosion when implanted in the human body 
43,44. 
Nickel-titanium alloy (Nitinol) 
The nickel-titanium (NiTi) alloy, also known as Nitinol, is a metal alloy with an 
approximately equiatomic composition of titanium (Ti) and nickel (Ni) 
(49-51 mol % of Ni) and shows unique mechanical properties such as shape 
memory, and superelasticity. Shape memory effect gives NiTi the ability to be 
deformed at one temperature, and then return to its original shape when being 
heated to its transformation temperature. Superelasticity occurs at specific 
temperature and allows the material to recover to its original shape after an 
apparent plastic deformation as soon as the stress is removed. Because of these 
unique properties, the NiTi alloy is used to fabricate guide wires, stents, 
orthodontic arch wires, and endodontic reamers, among others. The SMART 
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stent (Cordis, United States) and Radius stent (SciMED Live System, 
United States) are examples of NiTi BMSs currently used. However, the NiTi alloy 
usually exhibits crevice corrosion and pitting, and it corrodes during service in 
aortic endografts, where pitting and craters are observed on the alloy 45. 
2.1.2. CoCr alloys 
CoCr alloys show high strength, toughness, castability, corrosion resistance, and 
wear resistance. CoCr alloy was initially used as a cast alloy because working it 
is difficult due to its high hardness. The Wallstent, is made of Elgiloy, a 
40Co-20Cr-15Ni-7Mo-Mn alloy that was developed as a heat-resistant alloy. For 
biomedical use, cast Co–Cr–Mo alloys, commonly known as Vitallium alloys 
family, resist pitting and crevice corrosion. Because of the carbide in its structure, 
CoCr alloys have excellent wear resistance and are used for sliding parts of 
artificial joints.  
Wrought CoCr alloys, which are used for stents, were designed to avoid cast 
defects in cast CoCr alloys. The strength and elongation of wrought CoCr alloys, 
which increase with heat treatment and cold working, are as high as those of SS. 
The corrosion resistance of the wrought CoCr alloy is lower than that of cast CoCr 
alloy, but higher than that of SS. Therefore, wrought CoCr alloy is used for guide 
wires, clips, orthodontic arch wires, and catheters. 
Mainly, for the corrosion resistance properties, it has been decided to select CoCr 
alloy ASTM F90 to study metallic surface modification for cardiovascular 
applications. This alloy is a wrought 51Co-20Cr-15W-10Ni alloy for surgical 
implant applications. It has a Young’s modulus of 210 GPa and a unique ability 
to resist corrosion in very severe environments 46–48.  
 
2.2. Poly(L-lactic acid) (PLLA) for stents fabrication 
2.2.1. Biodegradable materials for stents 
DESs are made of a metallic core, generally CoCr alloy, stainless steel or Nitinol, 
covered by a polymeric coating containing drugs. Permanent polymer were used 
for the first DES generation 21,49–51. Next, biodegradables polymers coating were 
developed to reduce the long-term risks associated with the presence of a 
permanent polymer 16. These materials offer the attractive combination of 
controlled drug elution in parallel with biodegradation of the polymer into inert 
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monomers. Table I.2 shows DESs biodegradable materials used as coating, its 
mechanical properties and its observed clinical advantages and disadvantages.  
Few biodegradable polymers have been used for DESs coating: 
poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), 
polycaprolactone (PLC) and polyvinylpyrrolidone (PVP). Among them, only DESs 
with a PLA have been approved by the European Union (EU) with a Conformité 
Européenne marquage (CE mark). All the other DESs are under First-In-Man 
(FIM) or recent clinical studies. 
The polymers use for the SIMPLE II coating, a copolymer of PLC and PVP, 
induced non satisfactory clinical results and cannot be use for BRS because of 
its low mechanicals properties. The copolymers used for the Supralimus and 
Infinium coating was synthesized especially for this application and its properties 
are confidential.  
All the PLA coating show better clinical results than BMSs, including few LST and 
a better endothelial recovery. Finally, PLA have the highest mechanical 
properties, suggesting it could be also the best candidate for BRSs. 
  
Table I.2: Mechanical properties and clinical results of biodegradable polymers used as coatings for DESs. PLC: polycaprolactone; PVP: polyvinylpyrrolidone; 
PLGA: poly(lactic-co-glycolic acid); PLA: poly(lactic acid);  E: Youngs modulus; UTS: ultimate tensile strength; Tg: glass-transition temperature; FIM: first-in-man 
study; late loss: reduction of the lumen diameter in the 6 months after stent implantation. 
 
 
DESs Polymers State of investigation Clinical advantages Clinical disadvantages Mechanical properties Ref. 
Simple II PLC / PVP FIM ; not approved  Average  rate of in-stent 
angiographic restenosis and average 
late loss 
PLC properties: 
E = 30-200 MPa; 
UTS = 20-40 MPa 
Tg = -61ºC 
3,52 
Nevo stent PLGA Recent clinical studies; 
not approved 
Satisfactory binary ISR rates and 
in-stent late loss 
 E = 1-4 GPa; 
UTS = 41,4-55,2 MPa 
53,54 
Biomatrix stent PLA CE mark Few LST events; near complete 
endothelial recovery (>95%) 
 UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
53,55 
NOBORI PLA CE mark Significantly better  endothelial 
recovery than BMSs 
 UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
53,56 
Axxess PLA CE mark At 6-month follow-up, in-stent 
late loss was 0.09 mm 
80% and 42% of patients, 
respectively, required 2 or 3 
additional stents to cover the lesion 
UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
53,57 
XTENT PLA CE mark CoCr structure; modular design 
made up of multiple 6-mm 
segments that were interdigitated 
 UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
53,57 
JACTAX PLA Recent clinical studies; 
not approved 
  UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
53,57 
Supralimus  and 
Infinnium stent 
Copolymer 
(confidential) 
FIM ; not approved Rate of in-stent angiographic 
restenosis of 0.0%; low late loss 
  50,53,58  
Synergy stent PLGA Recent clinical studies; 
not approved 
 target lesion failure at 30 days E = 1-4 GPa; 
UTS = 41,4-55,2 MPa 
53,57 
   
 
Table I.3: Mechanical and degradation properties and clinical results of biodegradable polymers used for BRSs. PLLA: poly(L-lactic acid); 
PDLLA: poly(D,L-lactic acid); E: Young’s modulus; UTS: ultimate tensile strength; FIM: first-in-man study; late loss: reduction of the lumen diameter in the 
6 months after stent implantation; MACE: major adverse cardiac events; TLR: target lesion revascularization. 
 
BRSs Polymers Stat of investigation Clinical advantages Clinical disadvantages Properties Ref. 
IGAKI-
TAMAI 
stent 
PLLA Long human studies 
(more than 10 years); 
CE mark for 
peripheral arteries 
since 2007 
Non-drug eluting (PLLA without 
drug); a low complication rate; 
survival rates free from death, cardiac 
death, MACE, and TLR were 89%, 
98%, 60%, and 76%, respectively. 
Concern has arisen about 
the ability to apply heat, to 
self-expand the stent, 
without causing possible 
necrosis of the artery wall. 
UTS= 15-150MPa; 
E = 2,7-4,14 GPa; 
Degradable in 18-24 month. 
53,57,59 
Paclitaxel
-eluting 
PLLA 
PLLA Non-human studies; 
not approved 
reduced proliferation and stenosis after 
vascular intervention 
 UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
53,60 
ABSORB 
GT1 
PLLA (and a 
PDLLA coating 
with evrolimus 
inside) 
CE mark for coronary 
arteries since 2011; 
FDA approval in 
2016 
reduced in-stent late loss and a low 
MACE rate of 4.4%; few acute vessel 
recoil; no LST has been observed out 
to 3 years follow-up 
 UTS= 15-150MPa; 
E = 2,7-4,14 GPa 
Degradable in 24 month; 
radial support during 3 months 
35,36,53 
REVA 
stent 
Tyrosine 
polycarbonate 
FIM; not approved Improve acute recoil; minimal vessel 
shrinkage at follow-up 
Mechanical failure led to a 
higher than anticipated rate 
of target lesion 
revascularization 
Radio opaque; degradable in 
36 month; radial force 
comparable to a BMS 
61,62 
IDEAL 
BDS 
Poly(anhydride 
ester) (salicylic 
acid) 
FIM; not approved Successful results in pig coronary 
arteries; in human trials, absence of 
acute or chronic recoil; reduction in 
inflammation compared to BMS. 
Insufficient neointimal 
inhibition due to inadequate 
drug dosing and very quick 
elution of Sirolimus. 
Degradable in 12 months; 
radial strength greater than 
BMS; resistant to gamma 
radiation 
19,63 
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Table I.3 shows developed BRS, being all of them approved or under clinical trial. 
Tyrosine polycarbonate, used for the REVA stent, got correct FIM study results. 
However, it presents mechanicals failure associated with a too long polymer 
degradation and too recent studies. For these reasons it is preferable not to use 
tyrosine polycarbonate. 
Poly(anhydride ester) (salicylic acid), used for the IDEAL BRS, shows successful 
results in human trials, particularly an absence of acute or chronic recoil and a 
reduce inflammation compared to BMSs have been reported. This is the result of 
its high radial strength and its appropriate degradation rate. Also, the presence 
of salicylic acid in the polymer backbone permit to release drug without 
introducing drug inside the polymer. Insufficient neointimal inhibition is the only 
defect of this biodegradable polymer. 
2.2.2. PLLA 
PLLA and poly(D-lactic acid) (PDLA) are two different stereosisomers of PLA. For 
BRSs, PLLA has been chosen mainly for its higher crystallinity (about 37%) and, 
therefore, its higher mechanical properties (E = 3 GPa and UTS = 15-150 MPa; 
Table I.4).  
A semi-crystalline polymer (PLLA) is obtained from L-lactide.The special interest 
on PLLA to fabricate BRS is probably due to the fact that it is the biodegradable 
polymer with the highest mechanical properties 64. Also, among all biodegradable 
polymers, it has the slowest degradation rate 65, and, when obtained with a high 
molecular weight, it has been shown to take up to 5 years to be completely 
resorbed in vivo  66,67. PLA undergoes thermal degradation at temperatures 
above 200ºC mainly by hydrolysis, however, lactide reformation, oxidative main 
chain scission, and inter- or intra-molecular transesterification reactions also 
occur 68. PLA degradation is dependent on time, temperature, low-molecular-
weight impurities, and catalyst concentration 68. Also, PLLA used for BRSs have 
shown satisfactory clinical results, like particularly few major adverse cardiac 
events (MACE) and few thrombosis complication. Among them, the ABSORB 
GT1 is approved by the UE and the FDA for coronary arteries. 
To conclude, PLLA has already been used in many DESs and BRSs, it has all 
the mechanical and degradation properties necessary for the application and, it 
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presents multiples clinical studies with good results (Table I.4). Furthermore, the 
only two certified BRS are made of PLLA. 
Table I.4: Properties and clinical results of PLLA used in stent application. 
Stent necessary 
properties 
Optimum value PLLA 
High scaffolding Highest E 3 GPa 
High expansion ratio Highest UTS 15-150MPa 
Excellent corrosion 
resistance 
No corrosion before degradation Yes 
Good 
biocompatibility 
Good clinical results; few 
complication post stent implantation 
low complication rate; reduced in-stent late loss; 
low MACE rate of 4.4%; few acute vessel recoil 
Slow degradation 
Best time of polymer degradation: 
12 months 
12-24 month 
Thrombo-resistivity No thrombosis Few thrombosis cases 
Inexpensive to 
manufacture 
Cheap; easy-to process; easy-to buy  
Really well-known polymer; a lot of studies for 
stent application; not specially expensive 
 
3. Surface modification 
Surface properties of the implant are of great importance whenever it is implanted 
into living tissue. Biological interactions between the host tissue and the implant 
are mainly taking place at the surface of the device. The substrate surface can 
be designed to prevent or promote cell growth, stimulate or prevent blood 
clothing, attract or reject specific proteins, or in some other way control the 
biological response. 
Numerous investigations have been conducted to optimize surface implant 
biocompatibility and, at the same time, to obtain a bioactive surface. In 
cardiovascular field, an implant is bioactive if it induces reendothelization, 
reduces SMC proliferation or platelet aggregation. Consequently, main 
complications after stent implantation, ISR and LST, should be avoided.  The 
most common approaches to achieve such materials are (Figure I.6): 
 Topographical modification to obtain specific isotropic roughness or 
nano-micro patterns 19. 
 Chemical modification  in order to modulate surface functional groups, 
surface energy or surface electrostatic charge (NaOH etching, cold 
plasma, ozone, UV, among others) 19. 
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 Biofunctionalization of surface by immobilization of specific biomolecules 
which facilitates or activates a cascade of biological events and, 
eventually regenerates or replaces functioning tissue 69. 
 
Figure I.6: Examples of various physical, chemical, and biofunctionalization techniques to 
enhance hemocompatibility. Biofunctionalized surfaces interact with cell surface receptors, 
which are integrins. Whereas physiochemical modification can influence cell-material 
interactions through charge, topography, and attractive/repulsive forces due to hydrophobic and 
hydrophilic interactions 69. 
 
3.1. Topography 
3.1.1. Cell response to topography 
Surface roughness and texture of implants is known to influence biological 
response. Topography on the micro- and nano-metric scale is an important 
physical property, which influences protein adsorption, platelet adhesion, 
thrombogenicity, and cell behaviour. Originally, studies have suggested that a 
rough surface is more prone to thrombogenicity 70–72 and thus, surface treatments 
were essential to obtain a contamination-free and smooth surface for stent 
material applications. To obtain such stent surfaces various surface treatments 
are used, including mechanical polishing, electropolishing, ultrasonic cleaning, 
chemical etching and degreasing, as well as low-pressure plasma etching 73.  
Electropolishing possesses several compelling advantages that render it the 
most popular surface treatment method for polishing stents surfaces 74. 
Nowadays, the literature presents rather conflicting information about the exact 
role of topographical manipulation to platelet response, with a study reporting no 
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significant differences between platelet activation on smooth or nanoscale 
topographical surfaces 75. Other studies have shown that specific low roughness 
surfaces or nano-depth pattern can induce an antithrombogenic effect. For 
example, Chen et al. 76 showed that nano-micro patterned surfaces of TiO2 
presented lower platelet adhesion than on flat surfaces indicating that platelet 
activation may be dependent on the dimension of surface features as well as their 
aspect ratio. Certain nanostructured materials can have inherent 
antithrombogenic properties. If, in addition, high aspect ratio features are 
incorporated in their design then, platelet contact will be mainly limited to the tips 
of the nanopillars (or ‘hilltops’ and therefore, activation could be minimized 77,78. 
Meanwhile, several studies observed the behaviour of ECs on different 
substrates with different patterning structures such as grooves, pillars, pits and 
ridges at the nano- and micro-meter range 79–82. Numerous in vitro work 
demonstrated the importance of grooves on alignment of ECs promoting parallel 
migration, especially under low and normal stress conditions 79–82. Biela et al. 80 
showed that 10 µm width grooves induced ECs alignment and directed migration 
on silicon Si. Whereas, another study demonstrated a preferential orientation and 
elongation of ECs on anisotropically ordered ridges larger than 800 nm on a 
polyurethane substrate 81. Thus, it is no real consensus on determining which 
topographical features influence a certain cell lineage adhesion. 
3.1.2. Direct Laser Interference Patterning (DLIP) 
A range of physical techniques are actually applied to modify the surface 
topography of vascular graft materials: metallographic grinding, plasma etching, 
photolithographic etching, UV lithography, among others 50,83,84. Most of the 
employed processing techniques involve multiple preparation procedures 
incorporating coating and/or patterning steps. On the contrary, the Direct Laser 
Interference Patterning (DLIP) technique requires one single processing step 
and can be applied to a wide range of materials 85. The principle is based on the 
unique intensity pattern generated by interfering laser beams (Figure I.7), which 
show periodicities from the submicron range up to 50 µm. By photothermal 
interaction with the irradiated surfaces, the periodic patterns translate to the 
actual spacing factor of the afterwards topographically and/or chemically 
structured surface. 
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Figure I.7: Direct Laser Interference Patterning (DLIP) technique: (a) Beam configuration and 
principle of DLIP for a two beams set-up; (b) The calculated intensity distribution in case of two 
equal, interfering beams shows a line-like pattern with cos2(α) profile 86. 
 
Also, DLIP presents the possibility to obtain depth pattern lower than 20 nm which 
have never been elaborated for cardiovascular application. Finally, this technique 
has never been used in the cardiovascular field. Therefore, this PhD thesis 
proposes to use DLIP technique on CoCr alloy in order to obtain nano-micro 
patterned structure. To promote endothelial cells alignment and migration, lineal 
pattern will be design (Figure I.8). In addition, to study the influence of pattern 
depth on platelet adhesion, different pattern-depth will be fabricated. 
 
Figure I.8: Schematic representation of CoCr surfaces modification by DLIP technique and the 
expected effect on ECs and platelets response. 
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3.2. Chemistry 
Chemical methods are based on chemical reactions occurring at the surface of 
the material producing modifications of the chemical composition, structure, 
and/or stoichiometry of native materials surface.  
Modifying surface topography, as described in the previous section, influences 
also important chemical properties. For instance, rougher topography increases 
surface electrostatic charge and surface energy. Both properties have a strong 
impact on the interactions of the material with the surrounding biological system. 
That is the reason why all the techniques introduced in the previous section have 
been also used to modify surface chemical composition, and eventually to create 
chemical patterns 86. 
Other approaches to increase surface energy and hydrophilicity that produced 
promising in vitro and in vivo outcomes have been recently developed, such as 
cold plasma treatment 87–89 (Figure I.9), ultraviolet irradiation 90, sodium 
hydroxide (NaOH) etching 91,92 or ozone irradiation 93. 
 
 
Figure I.9: Scheme of polymer surface functionalization by plasma processes using air as gas for 
plasma generation 105. 
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For metallic alloys, chemical etching consists in the immersion of the samples 
into different acid (e.g. HCl, H2SO4, HNO3 and HF) 94 or alkaline (e.g. NaOH) 8,95 
chemical solutions. Depending on the chemical solution, the modified material 
can exhibit different reactivity. Thus, it is possible to induce the formation of a 
protecting layer by passivation or the dissolution and the flattening of surface 
defects. CoCr alloy reacts with alkaline solutions improving the formation of – OH 
groups on the CoCr surface due to the high pH solution. 
Also, enzymatic treatments have been proposed and successfully used for the 
surface modification of natural and synthetic polymers 96,97. For polyesters, such 
as PLLA, the hydrolysis of the ester bond by applying cutinase enzymes generate 
new hydroxyl and carboxyl groups onto the surface, which have been used to 
direct drug loading 98, to create superhydrophobic surfaces 99 or to bind serum 
albumin in order to increase biocompatibility 96. Different activation treatments 
work differently onto PLLA surfaces, while NaOH treatment is an aggressive 
non-selective hydrolysis that generates etching 100,101, oxygen plasma acts more 
superficially (< 1 µm) and according to treatment conditions generates unspecific 
functionalization, hydrolysis and eventually etching 102,103 and, cutinase enzyme 
allows a selective hydrolysis of the ester bonds of the outermost surface layers 
of the polymer generating only hydroxyl and carboxyl groups 100,104. 
3.3. Biofunctionalization 
The described methods to modify surface properties of implants do not change 
intrinsic bioinert chemical characteristics of the surfaces and, hence, are limited 
in improving their biological response. The strategies that aim on modifying the 
biochemical nature of the surface in order to create specific interactions with 
specific cells can be more promising and are introduced in the following sections. 
Biofunctionalization of surfaces is a strategic research field, which relies on the 
use of biology tools to create biomimetic surfaces to incorporate biologically 
active molecules to generate specific responses 106.        
The success of an implant relies on the establishment of strong and long lasting 
biochemical and mechanical interactions between the biomaterial and the 
surrounding endothelial tissue. The initial adhesion events of ECs on bioactive 
surfaces involve two distinct steps. An initial phase, where cells rapidly attach to 
the materials via physicochemical interactions (i.e. electrostatic forces, 
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hydrophobic interactions, hydrogen bonds, and van der Wall forces). And a 
second adhesive phase, in which cell adhesive proteins interact with each other 
and promote signal transduction and activation of long-term adhesion processes 
including cell proliferation and differentiation 107. 
Integrins represent the most prominent family of cell adhesion receptors, and 
have crucial roles in cellular processes that require cell attachment or growth of 
tissue. In particular, integrins mediate cell-cell contacts and cell adhesion to 
proteins of the extracellular matrix (ECM) 108,109. ECs express cell-surface 
integrins such as β1 108,110,111, which have the capacity to recognize and bind to 
ECM proteins. ECs ECM is composed of collagen 1, laminin, heparin and fibrin 
112. Modification of implant materials with biomolecules derived from ECM 
components represents thus, an attractive concept for biomaterial scientists to 
promote integrin-mediated binding of ECs and improve reendothelization. In the 
next sections, this approach will be described. 
3.3.1. Cell response to biofunctionalization 
Early studies investigated the use of natural, full-length ECM proteins to coat 
implant surfaces. These investigations included the use of collagen, heparin 113–
116, laminin 117 and  fibrin 118. Although this approach was proven to be successful 
to enhance cell adhesion on the functionalized surfaces, the use of proteins bears 
several disadvantages that precluded their widespread use and application. In 
the first place, proteins are enzymatically unstable and long-term functionality 
within the body would not be possible. In addition, protein production is usually 
performed in other organisms, and therefore its use in humans is associated with 
an increased risk of infections and adverse immune responses. Also, proteins are 
costly to produce in large amounts and their manipulation, modification and 
characterization for surface coating purposes is a demanding task. Last but not 
least, the conformation of the protein and/or the orientation of the bioactive motifs 
might be influenced by the physicochemical properties of the surface resulting in 
non-favorable presentations to support cell adhesion 119,120. 
Most of these drawbacks may be overcomed by using short ECM-derived 
peptides that contain the cell adhesive motifs, usually of only a few amino acids, 
present in the natural proteins (Figure I.10). Linear peptides are readily available 
using current solid phase peptide synthesis methodologies, and can be produced 
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in large quantities at a very low cost. They are easily characterized and 
functionalized for coating purposes. Moreover, due to lower steric requirements, 
they could be immobilized with higher density on solid supports compared to 
native ECM proteins. They are also much less sensitive to pH and temperature 
changes than full-length proteins. Finally, short linear peptides are not 
immunogenic and their use is exempt from infection risks. 
The RGD sequence (Arg-Gly-Asp) represents by far the most extensively 
studied cell adhesion motif used to functionalize surfaces and implant materials 
in order to stimulate cell attachment and adhesion, enhance cell migration and 
influence cell proliferation and differentiation 119. Since its discovery in 1984 as 
the minimal cell binding sequence in fibronectin 121, this tripeptide has also been 
identified in many other ECM proteins with cell adhesive properties. Thus, 
besides fibronectin, the RGD sequence was detected in fibrinogen, collagen type 
I, vitronectin, von Willebrand factor, osteopontin, laminin, tenascin and 
thrombospondin 122–124. Of the 24 known integrins, 8 receptor subtypes have 
been described to recognize and bind the RGD motif: αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, 
α5β1, α8β1 and αIIbβ3 108,109. As said before, ECs are known to express β1 integrins. 
Thus, it seems plausible that functionalization of surfaces with short RGD motifs 
might help to promote EC adhesion and reendothelization. The literature is full of 
examples of enhanced EC adhesion on matrices coated with short RGD peptides 
69,125,126. However, due to the presence of RGD receptors in most integrins, RGD 
motif binds with most integrins. Consequently, ECs adhesion to RGD is not 
specific and it is probable that RGD motif induces SMCs adhesion and platelets 
adhesion. 
Various ECM peptide sequences, which have been determined to influence 
specifically EC behavior, have been isolated and grafted on materials to enhance 
biological properties, for example, Arg-Glu-Asp-Val (REDV), 
Pro-His-Ser-Arg-Asn (PHSRN) and Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) from 
fibronectin, laminin-derived recognition sequences, Ile-Lys-Leu-Leu-Ile (IKLLI), 
Ile-Lys-Val-Ala-Val (IKVAV), Leu-Arg-Glu (LRE), Pro-Asp-Ser-Gly-Arg (PDSGR), 
and Tyr-Ile-Gly-Ser-Arg (YIGSR), and collagen type I derived sequence, 
Asp-Gly-Glu-Ala (DGEA). In particular, the laminin-derived peptide sequence 
YIGSR has demonstrated improved EC attachment, spreading and resistance to 
shear stress 127–129. Recently, Taite et al. incorporated polyethylene glycol (PEG) 
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and the YIGSR peptide into the backbone of polyurethane to improve the long-
term patency of polyurethane vascular grafts 130. The incorporation of PEG 
reduced platelet adhesion in vitro. Additionally, the incorporation of YIGSR 
peptide encouraged EC adhesion and SMCs did not adhere to YIGSR-containing 
polyurethane. 
 
Figure I.10: Strategies to biofunctionalize material surfaces with biomolecules. A) Adsorption of 
naturally occurring ECM proteins. These proteins contain cell adhesive motifs such as the RGD 
sequence; B) Immobilization of cell adhesive linear peptides, i.e. RGD peptides; C) Combination 
of linear peptides that synergize or act via distinct cell adhesive mechanisms; D) Use of peptides 
that bear multiple bioactive sequences in a controlled fashion; E) Multiple copies of the same 
epitope, e.g. multiple antigenic peptides (MAPs) of RGD peptides, may be used to increase cell 
adhesion; F) Engineered protein fragments presenting synergy domains required for selective cell 
adhesion, e.g. RGD and PHSRN direct α5β1-mediated adhesion; G) Immobilization of cyclic RGD 
peptides highly active and selective for integrins expressed by osteoblasts; H) Coating of surfaces 
with RGD peptidomimetic designed to be highly specific and stable to enzymatic degradation 131. 
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3.3.2. Design of biofunctional molecules 
The binding of the bioactive molecule to the metallic surface represents a critical 
step in the process of biofunctionalization. Thus, even peptide sequences with 
high cell adhesive potential may fail to promote cellular attachment if the 
immobilization of the biomolecules to the materials surface, and their 
presentation to cell‐surface receptors, are not optimal. 
The design of the biomolecule is a critical step to successfully immobilize it to the 
biomaterials surface. The main parts of a biomolecule and the desired 
characteristics of the surface for an optimal immobilization are the following 
(Figure I.11): 
1) The implant material: as we have previously mentioned the biological 
performance of a material strongly depends on its bulk and surface properties. In 
particular, the chemistry of the surface will determine the type of binding of the 
biomolecule to the material. 
2) The anchor is commonly a chemical group that allows a strong and selective 
binding of the peptide sequence to the surface. It is crucial that such attachment 
is long‐lasting and stable through all the process of implantation (e.g. stable to 
sterilization). In regard to the chemistry of the surface, distinct anchors might be 
used. For instance, thiols bind to gold and titanium/titanium oxide with high 
affinity; phosphonates to titanium/titanium oxide; and isothiocyanates to amino 
groups 119. Furthermore, surfaces may be functionalized with crosslinker 
molecules bearing specific functional chemical groups, thereby allowing a wide 
range of chemoselective reactions to attach molecules to the surface 119. 
3) A key element in a coating system usually underestimated is the spacer. This 
linker unit provides the required distance between the peptide motif and the 
surface material, in order to optimally present the bioactive sequence to 
cell-surface receptors. Taking as example RGD peptides, it has been reported 
that a minimum spacer is necessary to ensure a correct accessibility of the RGD 
sequence to the integrins and achieve cell adhesion 132,133. Chemical groups 
commonly used include aminohexanoic acid and polyethylene glycol (PEG). 
Choosing the right spacer, might be a difficult task, since not only the length but 
also other physicochemical properties need to be carefully considered. For 
instance, PEG chains offer an antifouling behavior that is useful to avoid 
non-specific protein adsorption, and to confer antimicrobial properties to the 
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surface 134; nonetheless, PEG‐based spacers are highly flexible and their use 
might result in bent conformations not accessible for the cells. 
4) Bioactive sequences useful to control the desired cell response.  
 
 
Figure I.11: Examples of designed biofunctional molecules. Green: anchoring sequence (Lys-Lys). 
Red: spacer units (Ahx-Ahx-Ahx). Blue: functional sequences (A: Arg-Gly-Asp-Ser and 
B: Tyr-Ile-Gly-Ser-Arg). 
 
3.3.3. Immobilization strategies 
There are three major strategies to biofunctionalize biomaterial surfaces: physical 
adsorption, physical entrapment or immobilization, and covalent attachment 135. 
Here, we will shortly focus only on the processes of physisorption and covalent 
binding. 
The process of physical adsorption, also known as physisorption, relies on 
the establishment of non-covalent interactions between the biomolecule and the 
surface. These interactions, which include hydrophobic and electrostatic 
interactions, van der Waal forces and hydrogen bonds, are weak but altogether 
may result in effective adsorption of biomolecules on a surface. The success of 
physical adsorption is therefore based on the physicochemical properties of the 
biomolecule and the surface properties (chemistry and energy) of the material. 
Although this approach is simple and fast, and has been widely used to 
immobilize proteins on the surface it is based on weak interactions, and therefore, 
the stability of the biological coating might be compromised at longterm and be 
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not optimal for clinical applications. Moreover, the adsorption of proteins into a 
surface takes place in a nonspecific manner and may result an unfavourable 
adsorption (i.e. adhesive sequences not accessible) thereby displaying reduced 
adhesive activities. 
The covalent immobilization of biomolecules onto surface materials offers an 
alternative which brings an improved stability to the biomaterial coating. Covalent 
immobilization is often used with short adhesive peptides which typically do not 
physisorb efficiently to metal surfaces, since they lack the minimum number of 
chemical groups to establish stable noncovalent interactions. Some authors refer 
to covalent immobilization as chemisorption, meaning that strong chemical 
bonds, ionic or covalent, bind stronlgy the surface and the biomolecule. To avoid 
that such irreversibly immobilization modifies the chemical structure of the active 
sequence, with concomitant loss of biological activity, the use of the appropriate 
anchors to bind covalently and selectively with the chemical groups of the 
surface, is highly recommended. These interesting and controlled characteristics 
makes covalent bonding as a preferred strategy over physical adsorption to 
immobilize biomolecules on metallic surfaces. 
Figure I.12: Examples of immobilization methods of cell adhesive peptides on CoCr alloy: physical 
adsorption and, covalent bonding through NaOH activation and CPTES silanization. Adapted 
from 8. 
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4. 3D printing for stent fabrication 
Stephen Nigro, president of HP Inc.'s 3D printer business, said ‘we're on the cusp 
of the Fourth Industrial Revolution’. This thesis also propose to evaluate the 
interest of the use of solvent-cast direct writing technique to obtain 3D-printed 
biodegradable stents.  
3D printing world is offering the possibility to obtain fully customized products. 
For this reason, biomaterials scientists are focusing their efforts on finding ways 
to use the different 3D printing technologies to obtain implants with a 
personalized shape to the treated patient. The idea is to acquire a 3D image of 
the damaged living tissue of the patient, to use this image to design the implant 
3D-shape and finally to fabricate a customized implant by 3D technologies. The 
most outstanding part of this solution being that the time between imaging 
acquisition and device implantation could be reduced to 2 days. Moreover, the 
stents can be also personalized to patient’s drugs needs.  
Due to the particularly complex cylindrical shape and low infill percentage of 
stents, few studies have been conducted to obtain 3D-printed stent. Particularly, 
no cardiovascular stent has been obtained by 3D printing due to the extremely 
low stent wire diameter (< 120 µm) and the use of other techniques. 
Although traditional 3D printing based on selective laser sintering (SLS), 
stereolithography (SAS) and fused deposition modeling (FDM) can provide a fast, 
reproducible and precise approach to generate biomaterials, these techniques 
would be probably too complex to adapt to obtain cardiovascular stent. On the 
other hand, 3D direct ink writing (DIW) techniques permit to print tridimensional 
biomaterials under milder conditions, without the need of high temperatures or 
invasive photopolymerization processes. 
DIW is an additive fabrication technique that includes all the 3D printing 
processes where an ink is extruded through a nozzle and plotted layer by layer 
in 3 dimensions 136,137. The ideal rheological behavior should present a gel-like 
consistency with a viscosity low enough to allow flowing through the nozzle when 
extruded 137. Moreover, the paste must have a pseudoplastic behavior in order to 
rapidly increase its viscosity once deposited providing a self-supporting structure 
138. Finally, the obtained structures should also resist the subsequent hardening 
steps or curing processes 139. 
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This technique has already been used with PLLA to obtain very complex shape 
with wire diameter inferior to 100 µm 140 (Figure I.13). For these reasons, we 
decided to adapt this technique to print a cylindrical stent on a rotating mandrel. 
 
 
Figure I.13: Different microstructures manufactured by 3D direct ink writing by Guo et al. 140. 
(a) Top and side view virtual images of the programmed DIW fabrication of the square spiral. 
(b) Top and side view SEM images of an actual PLA square spiral. (c) Inclined top view SEM image 
of a PLA circular spiral. (d) Representative optical image of a PLA scaffold composed of nine 
layers. (e) Inclined top view SEM image of PLA 9-layer scaffold. (f) SEM image of a PLA cup. 
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Chapter II: Aims and scope of the work 
  
Stenting is the most commonly performed procedure for the treatment of coronary 
atherosclerotic lesions and, according to medical diagnostic, BMSs, DESs or 
BRSs will be implanted. Both bare-metal CoCr and polymeric PLLA stents are 
widely used thanks to their excellent biocompatibility and optimal mechanical and 
corrosion properties. However, serious clinical complications remain, such ISR 
and LST, mainly due to delayed and poor reendothelialization of the surface. 
Surface modification is an excellent strategy to improve stent clinical results by 
enhancing endothelialization. Within this context, the global aim of this PhD thesis 
is to investigate new strategies of CoCr alloy and PLLA surface modification in 
order to control ECs and platelet response, and consequently, reduce ISR and 
LST rates after stent implantation. We believe that nano- and micro- patterning, 
biofunctionalization and chemical functionalization of stent surface could be 
potential strategies to induce an accelerated reendothelization of the stents. To 
that end, it will be studied different surface modification strategies on flat CoCr 
samples and on PLLA films. Moreover, the feasibility to fabricate BRSs by 3D 
printing will be also considered. The thesis has been divided into the three 
following strategies. 
 
Strategy 1: Design of different linear patterns using DLIP technique on CoCr 
alloy for cardiovascular applications and study their effect on ECs and platelets 
response. The following subgoals were considered: 
 Fabrication of nano-micro patterned CoCr alloy surfaces with DLIP 
technique. Creation of linear patterned CoCr surfaces with different 
periodicities and depths. Characterization of the topographical, chemical 
and physical properties of the obtained surfaces. 
 Biological characterization of the patterned CoCr surfaces. Study of 
the ECs and platelets adhesion response. 
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Strategy 2: Modification of CoCr alloy surfaces with a combination of linear 
patterning obtained by DLIP technique and biofunctionalization with RGD and 
YIGSR peptides to study the effect of both treatments in ECs adhesion, migration 
and proliferation. The following subgoals were considered: 
 Biofunctionalization of flat CoCr surfaces. Activation and 
biofunctionalization with RGD and YIGSR by covalent bonding through 
silanization. Characterization of the topographical, chemical and physical 
properties of the obtained surfaces. 
 Biological characterization of the biofunctionalized CoCr surfaces. 
Study of the ECs adhesion, proliferation and migration response. 
 Biofunctionalization of patterned CoCr surfaces. Activation and 
biofunctionalizion of the DLIP patterned CoCr surfaces with RGD and 
YIGSR by covalent bonding through silanization. 
 Biological characterization of the biofunctionalized and patterned. 
Study of the ECs adhesion, proliferation and migration response. 
 
Strategy 3: Elaboration of solvent-casted PLLA functionalized surfaces to 
enhance ECs adhesion and to assess the use of this process and biomaterial to 
fabricate 3D-printed BRS. 
 The following subgoals were considered: 
 Fabrication of PLLA films by solvent casting with enhanced 
mechanical properties. Optimization of the composition and the thermal 
treatments to fabricate PLLA films by solvent casting with mechanical and 
degradation properties comparable to actual BRSs. Characterization of 
the chemical, physical, mechanical and degradation properties. 
 Functionalization of PLLA surface. Optimization and generation of 
carboxyl groups on PLLA surface by oxygen plasma, NaOH etching and 
cutinase enzyme hydrolysis. Characterization of the chemical, physical 
and degradation properties. 
 Biological characterization of the functionalized PLLA surfaces.  
Study of the ECs adhesion response. 
 Fabrication of PLLA BRSs by 3D printing. Feasibility assessment of the 
fabrication of PLLA BRSs by the solvent-cast direct writes technique. 
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Chapter III: Direct Laser Interference 
Patterning of CoCr Alloy Surfaces to 
Control Endothelial Cell and Platelet 
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1. Introduction 
DLIP is a one-step technique that offers the possibility to obtain 
nano- depth (< 40 nm) patterns 1. Patterns are generated by the interaction of 
multiple laser beams onto the sample’s surface. In the case of metals, 
photothermal interaction is the responsible for the pattern formation. This results 
in the production of precise and distinct topographical and/or chemical surface 
patterns. DLIP has already shown promising results by inducing cells spreading 
and alignment on various biomaterials 2,3. We hypothesize that DLIP could be a 
useful strategy to produce modified stents that would promote faster endothelium 
recovery without increasing thrombus formation. 
The aim of this work is to obtain different linear patterns using DLIP on CoCr 
alloy for cardiovascular applications and study their effect on ECs and platelets 
response. Different pattern periodicities were designed according to ECs 
dimensions when adhering to metallic surfaces 4–7. Moreover, two different 
pattern depths were produced to evaluate their effect on platelet adhesion. The 
properties of modified CoCr surfaces were thoroughly characterized and EC and 
platelet response were examined in vitro. 
 
2. Materials and methods 
2.1. Materials 
CoCr discs of 10 mm diameter and 2 mm thick were obtained from a cylindrical 
bar of CoCr alloy ASTM F90 (51 % Co, 20% Cr, 15% W,10% Ni, 3% Fe) 
(Technalloy, Spain), abraded with silicon carbide grinding papers (P240, P600, 
P1200, P2500 and P4000 from Neuertek S.A., Spain) and finally polished with 
suspensions of 1 μm and 0.05 μm alumina in distilled water (Buehler, Germany), 
until achieving smooth mirror-like surfaces (Ra < 10 nm). All polished samples 
were ultrasonically cleaned with cyclohexane, isopropanol, ethanol, 
Milli-Q® water and acetone for 5 min. Finally, samples were dried with nitrogen. 
Human umbilical vein endothelial cells (HUVECs) (Lonza Group Ltd., 
Switzerland) were grown in EC basal medium (EBM®) supplemented with 
4% (v/v) fetal bovine serum (FBS), 0.1% (v/v) gentamicin sulphate amphotericin 
(GA-1000), 0.4% (v/v) recombinant human fibroblast growth factor (rhFGF), 
0.1% (v/v) recombinant human epidermal growth factor (rhEGF), 0.1% (v/v) 
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ascorbic acid, 0.1% (v/v) vascular endothelial growth factor (VEGF), 0.1% (v/v) 
recombinant Long R insulin (R3-IGF-1) and 0.04% (v/v) hydrocortisone (EBM 
and all supplements were obtained from Lonza). Cells were maintained at 37°C, 
in a humidified atmosphere containing 5% (v/v) CO2. The culture medium was 
changed every 2 days. Cell culture was performed in Nunc cell flasks 
(Thermo Fisher Scientific, USA) in completed medium. Upon reaching 70% 
confluence, cells were detached by trypsin/EDTA (Sigma-Aldrich), centrifuged 
and subcultured into a new flask or re-suspended in a serum-free medium and 
used for cell assays. All experiments were conducted using HUVECs at passages 
4 to 8 8,9.  
Whole blood samples were obtained from three healthy volunteers who had not 
taken any drugs affecting platelet function in the previous 10 days and minimally 
anticoagulated with citrate/phosphate/dextrose solution at a final citrate 
concentration of 19 mM (100 mM sodium citrate, 16 mM citric acid, 18 mM sodium 
hydrogen phosphate and 130 mM dextrose). 
2.2. DLIP technique 
A Nd:YAG laser (Spectra Physics Quanta-Ray PRO 290, Germany) with a 
fundamental wavelength of 1064 nm was used to modify the CoCr surfaces 
topography. Samples were structured at λ = 355 nm (third harmonic generation) 
in order to increase the energy absorbed by the CoCr surface. Repetition rate 
and pulse duration of the laser were 10 Hz and 10 ns. A mechanical shutter 
(Uniblitz Electronic, USA) was used for pulse number adjustment and a Solo 2 
laser power & energy meter (Gentec-eo, Canada) was placed on the laser beam 
trajectory to control and measure the power, from which fluency was calculated. 
A beam splitter was used to split the primary laser beam into two sub-beams. 
Three mirrors were used in different positions to make the 2 laser beams interfere 
on the sample surface with different angles (Figure III.1). Interfering two coherent 
beams results in a line-like interference pattern with a periodicity P related to the 
angle 2α between the two beams through the equation: P = λ / (2 ∗ sin(α)). A 
1×1 mm2 quadratic mask was placed just before the sample in order to use only 
the central part of the laser spot. The complete sample surface was structured 
with multiple, adjacent spots of 1×1 mm2. The laser treatment was performed at 
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normal atmospheric conditions using a single laser pulse. Further details of the 
experimental setup have already been published elsewhere 10. 
Patterns with four different periodicities 3 µm (3), 10 µm (10), 20 µm (20) and 
32 µm (32) were generated by modifying the angle. Also, laser fluency was varied 
to induce differences in the structure depth. Fluencies inferior to 1 J/cm2 were 
applied to generate low depth structures < 40 nm (L-pattern) and fluencies 
superior to 1.65 J/cm2 were used to obtain high depth structures > 600 nm 
(H-pattern). Thus, eight different surfaces with linear patterns were obtained: 3L, 
10L, 20L, 32L, 3H, 10H, 20H and 32H. 
 
Figure III.1: Fabrication steps of patterned CoCr surfaces by DLIP: 1) Configuration of the 
experimental DLIP setup; 2) Schema of the interference of the two laser beams onto CoCr flat 
surfaces; 3) Front- and top-view of the modified CoCr surfaces and simulation of the expected 
ECs adhesion orientation following the patterning. 
 
2.3.  Physico-chemical characterization  
2.3.1. Surface topography 
Surface morphology of the samples was analyzed by scanning electron 
microscopy (SEM) with a Zeiss Neon40 FE-SEM microscope (Carl Zeiss NTS 
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GmbH, Germany) with an acceleration voltage of 5 kV and at a working distance 
of 6 mm. For each series, fifteen images from three different samples were 
obtained at 5000x magnification.  
Topography was evaluated with white light interferometry (WLI) (Optical 
interferometer VeecoWyko 9300NT, Veeco Instruments, USA) in vertical 
scanning interferometry mode (VSI) at 100x magnification. Data analysis was 
performed with Wyko Vision 4.10 software (Veeco Instruments). Curvature and 
tilt were eliminated from every surface analysis with a Gaussian filter. Different 
parameters were quantified: periodicity (P); depth (D); aspect ratio P/D, 
roughness parameter Sa-micro (the arithmetic average height at a micro scale) and 
percentage of resolified surface. 
Also, nano-roughness of CoCr samples were analyzed by atomic force 
microscopy (AFM) (Dimension 3100, Veeco Digital Instruments, Bruker, 
Germany). Height and amplitude images were recorded simultaneously in 
tapping-mode in air using a silicon Tap150al-G cantilever (NanoWorld Group, 
Neuchâtel, Switzerland) at a scan rate of 1 Hz. Peaks and valleys areas of 
1x1 µm2 were analysed for CTR and patterned CoCr surfaces to obtain Sa-nano-peak 
and Sa-nano-valley, respectively. 
2.3.2. Chemical characterization 
The chemical composition of CoCr surfaces before and after the topographical 
modification was analysed by X-ray photoelectron spectroscopy (XPS) (SPECS 
Surface NanoAnalysis GmbH, Berlin, Germany). The XPS spectra were obtained 
using an Mg anode XR50 operating at 150W and a Phoibos 150 MCD-9 detector 
to record high resolution spectra at a pressure below 7.5 × 10−9 mbar. The 
elements present on the surface were evaluated by low-resolution survey 
spectra, whereas high-resolution of some elements (C 1s, O 1s, Cr 2p, Co 2p) 
were recorded with detector pass energy fixed at 25 eV with 0.1 eV step at a 
pressure below 7.5 × 10-9 mbar. Casa XPS software (Version 2.3.16, Casa 
Software Ltd., Teignmouth, UK) was used to do fitting, peak integration of spectra 
and peaks deconvolution. Binding energies were referred to the C 1s signal at 
284.8 eV. 
To determine metallic oxide layer thickness,  TEM lamellae for CTR, 10L and 
10H samples were prepared with the aid of a dual beam workstation, consisting 
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of a focused ion beam (FIB, Carl Zeiss NTS GmbH, Germany) used for site-
specific milling, and a SEM to image the samples. For TEM lamellae preparation, 
a Platinum-band (Pt) was deposited in-situ on the surface, first by electron and 
then by ion beam. The Pt-band aims to protect the surface during the ion milling 
steps, thereby ensuring the preservation of the original condition of the surfaces. 
The TEM investigations were carried out using a Jeol JEM 2010 at 200kV. 
Raman spectra were recorded with a Renishaw Qontor invia Raman 
microscope (Renishaw plc,Gloucestershire, UK) at 532 nm and 2400 l.mm-1 grid. 
A 100x magnifying microscope objective was used. For CTR, 3L and 3H eleven 
Raman spectra were taken along a line perpendicular to the laser patterning with 
a distance of 1 µm between each spot. In order to remove the background the 
remove background tool of Crystal Sleuth software was applied to all the spectra.  
2.3.3. Surface wettability  
Static contact angle was measured by sessile drop method with the 
video-based system Contact AngleSystem OCA15plus (Dataphysics, Germany). 
Drops were generated with a micrometric syringe and deposited on the substrate 
surface. Milli-Q® water contact angle was measured on modified CoCr surfaces 
following the perpendicular (Ɵxeq) and parallel (Ɵyeq) directions to the patterns. 
For each condition, it was measured 20-25 drops of 3 µl each and the contact 
angle values were obtained after applying Laplace-Young fitting of the drop 
profile with SCA 20 software (Dataphysics). Since the samples were not smooth, 
Wenzel equation was applied to obtain the intrinsic contact angle (): 
cos(eq)=r*cos() where r is the index area: 
real surface area / projected surface area. Finally, the difference between the 
parallel and the perpendicular contact angle was calculated as Δ = |x - y|, as 
a parameter to quantify the surface anisotropy. 
2.4. Biological characterization 
2.4.1. Blood perfusion assay  
Platelet adhesion studies were carried out using a flat chamber perfusion 
system 11–13, where two samples can be tested in parallel. CoCr samples of ≈170 
µm thickness were prepared for each perfusion and patterned CoCr surfaces 
were aligned with the blood flow. Blood from 3 volunteer donors, was circulating 
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through the perfusion chamber at a shear rate of  800 s-1 during 5 min at 37ºC 13. 
After perfusion, samples were rinsed thrice with 0.15 M PBS. To stain the 
platelets by fluorescence, adherent platelets were fixed with 2.5% glutaraldehyde 
in 0.15 M PBS at 4ºC during 24 h. Then, blocking step was performed with a 
solution of 1 % BSA (w/v) in PBS for 15 min at room temperature (RT) with orbital 
agitation at 100 rpm. Primary antibody monoclonal mouse anti-human CD36 
(1:2000) (Clone 185-1G2, Lifespan, Biosciences, USA) was incubated in 1 % 
BSA (w/v) in PBS for 1 h. Samples were washed thrice with PBS during 5 min 
and then, the surfaces were incubated with secondary antibody donkey anti-
mouse IgG- AF 594 (1:500) in 1 % BSA (w/v) in PBS for 1 h in dark. Finally, 
samples were washed with PBS and Milli-Q® water and mounted on microscope 
slides with Prolong Gold Antifade reagent (Thermo Fisher Scientific, USA). 
Surfaces were examined by AF7000 fluorescence microscopy (Leica). Images at 
10 X magnification from the entire sample surface were acquired and analysed 
with FIJI Image J software by measuring the percentage of the surface covered 
with platelets and the average size of the aggregates. Finally, platelets were fixed 
with glutaraldehyde (G400-4, Sigma-Aldrich) and dehydrated through immersion 
in different solutions of ethanol in order to observe platelet aggregates with more 
details by scanning electron microscopy (SEM) with a Zeiss Neon40 FE-SEM 
microscope (Carl Zeiss NTS GmbH, Germany). For each sample, five images 
were taken at a working distance of 6 mm and a potential of 5 kV. 
2.4.2. Cell adhesion 
Cell adhesion assay was performed by seeding HUVEC at a density of 5 x 104 
cells/disk with serum-free medium and cellular analyses were carried out at 12 h 
after cell seeding. The different CoCr samples were previously sterilised in 
ethanol 70% during 15 min at RT. Polished CoCr was used as a control.  
To quantify the density of adhered HUVECs the release of lactate 
dehydrogenase (LDH) enzyme was measured at the specified culture time. For 
that purpose, cells were lysed with 350 μl/disk of mammalian protein extraction 
reagent (M-PER) (Thermo Fisher Scientific, USA) and the activity of LDH was 
measured by means of a conventional colorimetric assay (Cytotoxicity Detection 
Kit, Roche Diagnostics, Mannheim, Germany).  The reduction in tetrazolium salts 
into formazan dye, an enzymatic reaction coupled to LDH activity, was measured 
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spectrophotometrically at 490 nm using the microplate reader Infinite M200 PRO 
(Tecan Group Ltd., Switzerland). A calibration curve with decreasing number of 
cells was performed to express the obtained absorbance results as cell number. 
To characterize HUVECs alignment and spreading, staining of nuclei and actin 
fibers was performed by immunofluorescence. Briefly, adhered cells were fixed 
with 4% (w/v) paraformaldehyde (PFA) for 30 min and permeabilized with 0.05% 
(w/v) Triton X-100 in PBS at room temperature for 20 min and washed with 20 
mM glycine in PBS (×3). Samples were blocked with 1% BSA (w/v) in PBS for 30 
min. Next, cells were dark incubated with phalloidin-rhodamine (1:300; Invitrogen, 
USA) for one hour. After, samples were washed with 20 mM glycine in PBS (×3) 
and nuclei were counterstained with DAPI (1:1000; Invitrogen) in dark during 
2 min. Finally, samples were mounted in Mowiol 4−88 (Sigma-Aldrich) on 
microscope slides before visualizing in an AF7000 fluorescence microscope 
(Leica, Germany). Images at 10 X magnification from the entire sample surface 
were stitched and cell spreading and morphology was determined by measuring 
three different characteristics: cells mean area, cells aspect ratio (maximum ratio 
of length and width of a bounding rectangle for the cell) and percentage of aligned 
cells (percentage of cells with an angle inferior to 30 % between the cell 
orientation and the pattern lines) using FIJI ImageJ software 14. Once analyzed, 
CoCr samples were ultrasonically cleaned in PBS and adhered cells were fixed 
with glutaraldehyde (G400-4, Sigma-Aldrich) and dehydrated through immersion 
in different solutions of ethanol in order to observe in more in detail the cells 
shape by SEM. For each sample, five images were taken at a working distance 
of 6 mm and a potential of 5 kV. 
2.4.3. Cell migration 
To evaluate the process of wound healing and cell migration onto CTR, 10L and 
10H CoCr surfaces, HUVECs were stained with the cell membrane fluorescent 
linker PKH67 (PKH67-GL, Sigma-Aldrich) 24 h prior to wound healing assays. 
Before cell culture, CoCr samples were sterilized in ethanol 70% for 20 min at RT. 
The wound healing processes were reproduced by placing an Ibidi culture-insert 
(Ibidi, Germany) on top of each sample. On the patterned surfaces the Ibidi insert 
was placed in order to have the gap perpendicular to the patterns lines. Thus, a 
suspension of 20 000 labelled cells/disk were placed at both chambers of the 
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insert with complete medium, and incubated for 24 h until reaching a confluent 
HUVEC adhesion. After, the insert was removed creating a cell-free gap of 500 
µm ± 50 µm. The surfaces were cleaned twice with PBS to remove non-adhered 
cells and thus, filled with complete medium. HUVEC cell migration was recorded 
using a fluorescence stereomicroscope (Leica MZ16F, Leica microsystems, 
Germany) combined with the camera DFC 300 FX (Leica Microsystems). Gap 
images were acquired for all the samples at 0 h and 48 h. The non-covered area 
for each CoCr disk was calculated with FIJI Image J software and the percentage 
of gap recovery was calculated for each series. 
2.5. Statistical analysis  
The experimental data collected in this chapter are reported as 
mean ± standard deviation. A one-way analysis of variance (ANOVA) was used 
to determine the statistical significance of difference at p<0.05 (Minitab 16.2.2 
Statistical Software, Minitab Inc.). Unless previously specified, all 
physicochemical characterization and cell culture experiments were performed 
with n=3 samples for each specimen group for each assay used in this study. In 
addition, each experiment was repeated at least twice. 
 
3. Results and discussion 
3.1. Physico-chemical characterization 
3.1.1. Surface topography 
For the first time, CoCr surfaces were modified creating controlled patterns of 
different widths and depths by DLIP technique as observed by SEM (Figure III.2) 
and analysed by white light interferometry (WLI) (Figure III.3 and Table III.1). 
Modifying laser beams incident angle and fluency allowed to obtain four different 
periodicities 3 µm (3), 10 µm (10), 20 µm (20) and 32 µm (32) and two different 
depths: low depth structures < 40 nm (L-pattern) and high depth structures 
> 600 nm (H-pattern). Thus, eight different surfaces with linear patterns were 
obtained: 3L, 10L, 20L, 32L, 3H, 10H, 20H and 32H. In order to minimize platelet 
adhesion and aggregation, L-pattern surfaces were designed to have a very low 
depth and roughness while H-pattern series were intended to enhance HUVECs 
alignment and adhesion. As reported by other authors, when the surface 
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roughness is sufficiently low, it is expected that platelets do not sense roughness 
and do not adhere to these substrates 15,16. In contrast, H-patterned surfaces are 
considerably rougher than CTR and L-pattern series and its depth is higher than 
600 nm which was expected to control ECs adhesion 17,18. 
Generally, the modified surfaces present a linear pattern except for 32L which 
shows linear circular waves. As expected, H-pattern series present higher depths 
compared to L-pattern and peaks and valleys are well defined and homogeneous; 
whereas L-pattern series present less defined structures than H-pattern.  
 
Figure III.2: SEM images of plain CoCr (CTR) and the different patterned structures obtained by 
DLIP. Scale bar = 10 µm. 
 
To understand the generation of peaks by DLIP technique onto CoCr surfaces, 
Figure III.3 shows the cross-section WLI profile of surfaces 32H and 32L as an 
example that can be translated to the others surface patterns. The profile of 32H 
surfaces presents one valley in front of the constructive interference and one 
single peak in front of the destructive interference. H-pattern surfaces present 
only a peak for each periodicity, as confirmed by SEM and WLI, and the overall 
surface is composed of melted CoCr. On the other hand, L-pattern series are 
composed of a small valley at the constructive interferences area, accompanied 
by small peaks at both sides of this valley, and a non-modified and non-melted 
flat area at the destructive interference areas. 
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Figure III.3: WLI cross-section profiles superposition of 32H (A) and 32L (B) surfaces: i) initial 
surface (dot line); ii) final patterned surface (light grey); iii) estimated non-modified CoCr (dark 
grey). Constructive interferences are indicated with arrows.  
 
Table III.1: Surface topography and wettability parameters of CTR and patterned CoCr surfaces 
measured by WLI, AFM and contact angle. Different columns correspond to: Laser fluency,  
periodicity (P), depth ( D), aspect ratio ( P/ D), arithmetic roughness average (Sa-micro, Sa-nano-peak, 
Sa-nano-valley), percentage of resolidified surface, intrinsic contact angle perpendicular to pattern 
direction (ϴx), intrinsic contact angle parallel to pattern (ϴy) and Δϴ = |ϴx - ϴy|. 
    Surface topography  Wettability 
  Surfaces 
Laser 
Fluency 
 
P D 
Aspect 
Ratio P/D 
Sa-micro  Sa-nano-peak Sa-nano-valley 
Resolidified 
surface 
 
ϴx ϴy Δϴ 
  J/cm2  µm nm - nm nm nm %  ⁰ ⁰ ⁰ 
 CTR -  - - - 7.4 ± 5.3 0.63 ± 0.32 
- 
0  70.3 ± 3.0 0.0 
Lo
w
 
3L 0.91  3.4 ± 0.1 5.6 ± 0.7 614.3 27.4 ± 6,3 0.60 ± 0.17 0.67 ± 0.25 68 ± 9  80.2 ± 3.8 78.9 ± 6.1 1.3 
10L 0.81  10.0 ± 0.1 30.1 ± 9.3 330.8 28.2 ± 12.5 0.70 ± 0.33 0.50 ± 0.15 65 ± 7  78.5 ± 8.8 79.4 ± 9.3 0.9 
20L 0.93  19.5 ± 0.1 25.8 ± 9.6 757.5 15.8 ± 1.1 0.57 ± 0.20 0.68 ± 0.22 64 ± 6  81.1 ± 4.6 81.3 ± 3.6 0.2 
32L 0.93  32.5 ± 0.3 34.1 ± 11.0 925.3 33.4 ± 11.9 0.69 ± 0.15  0.63 ± 0.20 68 ± 11  80.4 ± 6.9 79.8 ± 6.4 0.6 
H
ig
h
 
3H 1.65  3.4  ± 0.0 636.8 ± 132.3 5.4 174.9 ± 28.0 0.72 ± 0.21 0.51 ± 0.14 100 ± 0  80.1 ± 5.0 76.7 ± 8.8 3.4 
10H 2.42  10.0 ± 0.1 733.6 ± 104.6 13.4 299.8 ± 35.9 0.68 ± 0.21 0.69 ± 0.19 100 ±0  93.0 ± 7.0 82.6 ± 6.1 10.4 
20H 3.21  19.5 ± 0.1 963.0 ± 109.2 20.3 279.0 ± 31.6 0.62 ± 0.27 0.67 ± 0.19 97 ± 2  93.7 ± 4.5 84.6 ± 5.4 9.1 
32H 5.00  32.4 ± 0.4 997.8 ± 124.8 32.5 264.9 ± 65.7 0.55 ± 0.18 0.58 ± 0.15 98 ± 2  99.4 ± 6.8 88.8 ± 7.1 10.6 
 
Table III.1 summarizes the analysed parameters of the different surfaces with 
WLI and AFM technique. For L-pattern, it has been used a low laser fluency, 
between 0.81 and 0.93 J/cm2, whereas, for H-patterns it was necessary a higher 
fluency between 1.65 and 5 J/cm2. WLI confirmed the modification of CoCr 
surfaces to be very reproducible for each of the generated periodicities (3, 10, 20 
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and 32 µm). As expected, the different series show extreme depths ranging from 
5.6 to 34.1 µm for L-pattern surfaces and from 636.8 to 997.8 µm for H-pattern. 
These depth differences on L- and H-patterns lead to a very different aspect ratio 
P/D around 800 and 20, respectively. Concerning Sa-micro parameter, L-pattern 
surfaces show a roughness slightly higher to CTR and H-pattern presented, at 
least, values of Sa-micro 20 times higher than CTR. On the contrary, Sa-nano-peak and 
Sa-nano-valley obtained from AFM images (Figure III.4 and Table III.1) on all 
patterned surfaces presented no statistical differences compared to Sa-nano on 
CTR, indicating that DLIP technique did not modify the nano-roughness at peaks 
or valleys of the studied surfaces. 
 
Figure III.4: AFM analysis of 20L and 20H surfaces to characterize the patterns topographical 
properties. AFM amplitude images of 20L and 20H surfaces. Scale bar = 10 μm. Black squares 1, 
2, 3 and 4 represent the studied 1x1 µm areas to obtain Sa-nano-peak(10L), Sa-nano-valley(10L), 
Sa-nano-peak(10L), Sa-nano-valley(10L), respectively.  
 
The analysis of the percentage of resolidified surface indicates that L-patterns 
have between 64 and 68%, while, H-patterns present values higher than 97%. 
Specifically, 3H and 10H surfaces have 100% of resolidified surface and 20H and 
32H, only present, respectively, 3 and 2% of non-modified surface. DLIP 
technique applied to metals generates melting of the surface layer at the 
constructive interference and the molten metal flows to the destructive 
interference zone due to the surface tension gradient induced by the difference 
of temperatures 19,20. If the applied fluency is enough, two consecutive 
constructive interferences can melt enough material to form a single peak 
between them and consequently, cover the entire surface with molten and 
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resolidified material. According to SEM images and WLI profiles, this is the 
process that occurred with the H-patterned series. Indeed, these structures 
presented a clear single-peak pattern associated with a surface almost fully 
covered by resolidified metal. On the other hand, as observed by SEM images 
and WLI profile, the low fluency used for the L-surface series generated lower 
metal melting fronts, which did not join in a single peak. Then, two peaks were 
obtained as a result from two consecutive constructive interferences and less 
than 68% of the surface was covered by resolidified metal. 
3.1.2. Chemical characterization 
Surface chemical composition of the studied CoCr surfaces is shown in Table 
III.2. XPS analysis revealed the presence of Co 2p, Cr 2p, C 1s and O 1s. The 
atomic percentage of C 1s increased while O 1s decreased for patterned surfaces 
compared to CTR. The relatively high percentage of C 1s detected in all studied 
surfaces was associated with the presence of organic contaminants from the air. 
All patterned surfaces present higher content in Co 2p compared to CTR, 
whereas, Cr 2p element increased only for L-pattern and 3H. The relationship 
between the two principal elements was measured by the ratio Co/Cr, which 
increased from 0.37, for CTR up to 2.02 in the case of 32H. This increase of the 
Co/Cr ratio was correlated to the laser fluency used to obtain the patterned 
surfaces. Indeed for the surfaces patterned with the lowest fluency (0.91 J/cm2)  
Co/Cr ratio increased up to two times compared to CTR (i.e. 0.8 and 0.4 for 10L 
and CTR respectively) and up to five times (2.0 for 32H) for the surfaces 
patterned with the highest fluency (5 J/cm2). This higher amount of Co found at 
the surface could be explained by the higher diffusivity of Co compared to Cr at 
high temperatures generated by DLIP 21. 
The deconvolution of the high-resolution Co 2p and Cr 2p peaks has been 
applied for all the samples. The ratios between the metallic fraction and the oxide 
fraction for Co and Cr elements, Co/CoxOy and Cr/Cr2O3 can be visualized in 
Table III.2. CoxOy corresponds to CoO or Co3O4 oxides, which have equal energy 
binding peaks at 779.7 eV 22,23. Figure III.5 shows the comparison between the 
deconvolution of the Co 2p peak of CTR, 20L and 20H.   
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Table III.2: Analysis of the atomic composition percentage at the CTR and patterned surfaces 
by XPS. Values of  O 1s, C 1s, Co 2p, Cr 2p  and ratio between Co/Cr and metallic/oxide fraction 
for Co  2p (Co/CoxOy) and Cr 2p (Cr/Cr2O3) obtained from the deconvolution of Co 2p and Cr 2p 
peaks. CoxCy corresponds to CoO or Co3O4 oxides. 
 
Surfaces 
Elemental composition (atomic %) 
Co/Cr Co/CoxOy Cr/Cr2O3 
 O 1s C 1s Co 2p Cr 2p 
 CTR 52.4 36.5 3.0 8.1 0.4 1.09 0.09 
Lo
w
 
3L 25.2 51.4 9.3 14.1 0.7 0.29 0.05 
10L 24.9 49.9 11.6 13.7 0.8 0.27 0.06 
20L 35.1 46.8 7.6 10.5 0.7 0.25 0.07 
32L 24.9 51.4 13.2 10.5 1.3 0.15 0.05 
H
ig
h
 
3H 26.3 53.4 9.1 11.3 0.8 0.17 0.04 
10H 52.8 39.4 4.5 3.3 1.4 0.00 0.00 
20H 44.0 45.9 6.1 4.0 1.5 0.00 0.00 
32H 33.9 52.0 9.5 4.7 2.0 0.00 0.00 
 
 
Figure III.5: High-resolution spectra of Co 2p for CTR, 20L and 20H surfaces obtained by XPS. 
Dashed lines represent the deconvoluted peaks. 
 
When determining changes in the ratio Co/CoxOy, XPS showed an increase of 
this parameter depending on the used laser fluency. XPS analyses a 10 nm layer 
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of the material, and therefore the Co/CoxOy ratio of 1.09 observed for the CTR 
sample means that there is approximately the same amount of metallic cobalt 
and cobalt. For 10H, 20H and 32H the ratio was 0 meaning that the oxide layer 
of these surfaces was thicker than 10 nm. Finally, on L-pattern surfaces, an 
intermediate situation was found with Co/CoxOy ratio around 0.2, suggesting that 
L-series had an oxide layer thicker than CTR and thinner than H-pattern surfaces. 
Similar tendencies were obtained with Cr 2p . Indeed, Cr/Cr2O3 decrease on L-
patterns and 3H compared to CTR and on 10H, 20H and 32H the ratio is null. 
Transmission electron microscope (TEM) lamellae were prepared from CTR, 10L 
and 10H samples to characterize the oxide layer thickness (Figure III.6). CTR 
presented a homogeneous oxide layer of 2.1 nm thickness. After DLIP technique, 
oxide layer thickness increased slightly on 10L, between 3.1 and 3.9 nm, and, 
more significantly on 10H, > 11.4 nm. Both 10L and 10H surfaces, did not present 
differences between peaks and valleys of the topography, suggesting that the 
oxidation consequence of DLIP technique was homogeneous. 
 
Figure III.6: TEM investigation of the oxide layer modification during laser structuring of CoCr 
alloy. High magnification of oxide layer thickness for CTR, 10L and 10H surfaces. The upper part 
of the images correspond to the CoCr alloy, the black layer correspond to the Pt-band and the 
bright layer in-between is the oxide layer.  
 
Raman spectrum profiles were obtained for CTR, 3L and 3H series, by performing 
the analysis perpendicularly to patterns direction in order to have information 
about peaks and valleys oxide layer properties (Figure III.7). Generally, the 
analyzed spectrums presented the following peaks: Co3O4 at around 190, 470, 
510 and 670 cm-1 24,25 and Cr2O3 at 250, 510 and 540 cm-1 26,27. Differences on 
the intensity of the peaks were detected between the different series. As 
expected, CTR Raman spectrums presented sharp Co3O4 and Cr2O3 peaks 
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indicating that these oxides were crystalline. On 3L and 3H surfaces a significant 
reduction or disappearance of the previous peaks was observed. As XPS and 
TEM indicated an increase of the oxide layer thickness on patterned surfaces 
compared to CTR, the reason for such peaks intensity decrease could be 
associated with a partial transformation of the crystalline Co3O4 and Cr2O3 oxide 
layer to a thicker amorphous oxide layer. As the sample surface is submitted to 
extremely high temperatures for a short period of time during DLIP 28, it was 
reasonable to observe amorphous oxide layer on L- and H-pattern surface. Both 
surfaces, 3L and 3H, did not present significant differences of the Raman spectra 
between peaks and valleys, confirming the homogeneity of the oxide layer 
composition all over the surfaces. 
Figure III.7: Raman spectra measurements results for the CTR (red), 3L (black) and 3H (blue) 
samples. For all studied conditions, each line corresponds to a Raman spectrum taken along a 
line perpendicular to the laser patterning with a distance of 1 µm between each spot. 
 
3.1.3. Surface wettability 
The sessile drop method was used to measure the static contact angle of 
distilled water (Milli-Q®, Merck Millipore, USA) onto patterned CoCr at two 
orientations, perpendicular and parallel to the patterns lines. Then, the Wenzel 
equation was used to calculate the intrinsic contact angles of the different 
surfaces with a surface area index r of 1.0 for CTR and L-patterns and of 1.1 for 
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H-patterns. Table III.1 shows the results obtained for both directions and the 
difference between these two angles.  
As observed, CTR surfaces have a contact angle of 70.3 ± 3.0º whereas, all 
patterned surfaces are more hydrophobic and show values ranging from 76.7º up 
to 99.4º in both directions. The contact angle increased as the pattern periodicity 
and depth increased. A previous study demonstrated that a titanium amorphous 
oxide surface had a more hydrophobic behavior than its respective crystalline 
oxide structure 29. In accordance, the hydrophobic effect of CoCr surfaces 
modified by DLIP technique was a consequence of the generation of an 
amorphous oxide layer. 
Δ, as an indicator of heterogeneity, is null for CTR and very low for L-pattern 
series; while for H-pattern it is > 3.4º  and particularly 10H, 20H and 32H have a 
significantly higher x than y indicating anisotropic wettability on H-pattern. 
This effect was visually confirmed through the optical microscopy images 
(Figure III.8). Indeed, on 32L the water droplet is perfectly circular whereas on 
10H the drop shows an oval shape depending on the direction of the pattern. The 
enlarged image of a deposited drop on 10H showed that peaks blocked the water 
deposition when it was perpendicular to the pattern lines, resulting in oval drop 
geometry. This anisotropic wettability on laser modified samples was already 
reported by other authors with Cu and Ti substrates 20,30, suggesting that DLIP 
topographical patterns induced, in general, an anisotropic wettability on metals 
which could influence protein adsorption 31 and, indeed, cell spreading. 
 
Figure III.8: Optical microscope images of the deposition of a distilled water drop on 32L and 10H 
surfaces and an enlarged rotated image of deposited drop on 10H. 
 
These results prove that DLIP technique allows obtaining surface modification 
onto metals with very different characteristics. Both, L- and H-pattern surfaces, 
presented surface modifications such as changes in the oxide chemical 
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composition, a partial transformation of the structure from a crystalline to a thicker 
amorphous oxide layer and an increased hydrophobicity. Overall, H-pattern 
series presented a controlled topographical pattern while L-pattern surfaces had 
negligible topographical modifications. In fact, L-pattern surfaces can be used as 
a model of chemical surface modifications without topographic changes for DLIP 
studies, when it is desired to study separately the effect of chemical properties 
and topography. In this study, it helped to understand the biological response of 
HUVECs and platelets on DLIP modified surfaces. 
3.2. Biological characterization 
3.2.1. Platelet adhesion and aggregation  
To evaluate platelet adhesion and aggregate size, all surfaces were placed into 
a flat perfusion chamber circulating donor’s blood at a shear rate of 800 s-1 during 
5 minutes. Attached platelets were visualized by fluorescent labeling the 
membrane and also, after dehydration, with SEM (Figure III.9). As it is well 
known, roughness increases platelet adhesion and aggregation 16,32,33. Thus, it 
was expected to observe a higher platelet adhesion on DLIP surfaces, particularly 
on H-pattern. Surprisingly, both H- and L- pattern surfaces presented a 
statistically significant lower area covered by platelets and lower platelet 
aggregation size than CTR, irrespective of pattern periodicity. Indeed, CTR 
showed 33.0 ± 3.7 % of the area covered by platelets whereas all patterned 
surfaces obtained values lower than 17.4 ± 6.6 %. All patterned CoCr surfaces 
showed platelets aggregates size lower than 96.7 ± 19.1 μm2 compared to CTR, 
200.6 ± 33.3 μm2. This behavior was confirmed by SEM images (Figure III.9C) 
where it is observed that platelet aggregates were bigger on CTR than on 10L 
and 10H, respectively. This behavior was a consequence of chemical or/and 
topographical surface modifications induced by DLIP onto both, L- and H-
patterned surfaces. As DLIP induced negligible topographical modifications, at 
the nano- and micro-scales, on L-pattern series compared to CTR, topographical 
modifications cannot explain the reduced platelet adhesion. This was confirmed 
by SEM images where platelets adhered randomly on peaks and valleys on all 
patterned surfaces. Consequently, chemical modifications on L- and H-pattern 
surfaces, in particular changes in oxide layer properties and increased wettability 
were  probably  the  reasons  for  such  reduction.  This  was  in  agreement  with 
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Figure III.9: Platelet adhesion study on CTR and DLIP patterned surfaces by circulating donor’s 
blood flow during 5 minutes in a flat perfusion chamber at shear rate of 800 s-1. (A) % of the area 
occupied by platelets and platelet aggregates size measured by fluorescent microscopy. Images 
were analysed with FIJI software. Columns with different letters belong to statistically different 
groups (p-value < 0.05). (B) Fluorescence microscopy images of adhered platelets on CTR and 
patterned surfaces. Bar = 75 μm. (C) SEM images of platelet aggregates on CTR, 10L and 10H 
surfaces.  Black arrows indicate platelet aggregates. Bar = 10 μm.  
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previous studies that demonstrated a lower platelet adhesion when the oxide 
layer thickness increased 34,35 as occurred for patterned surfaces compared to 
CTR. Oxide layer modifications modulate proteins adsorption onto the biomaterial 
surface, i.e. fibrinogen and kininogen adsorption and determine platelet adhesion 
34,36. Also, other studies suggested that titanium amorphous oxide could improve 
blood compatibility or reduce the activation of the clotting cascade compared to 
a more crystalline metallic oxide 37,38. Moreover, it was described that for surfaces 
with a wettability range between 60-100⁰, platelets adhered preferentially on 
surfaces with a contact angle around 60⁰ than onto surfaces with 100⁰ wettability  
39–41 . This was the behavior of CTR, with a contact angle of 70º compared to 
patterned series with a higher hydrophobicity, 80-100º. Consequently, the 
transformation of a CoCr alloy crystalline oxide layer to a thicker amorphous oxide 
layer and the associated increased hydrophobicity could explain the decrease of 
platelet adhesion and aggregation onto patterned CoCr surfaces compared to 
non-modified and smooth surfaces. 
3.2.2. Cell adhesion 
To characterize the effect of the different DLIP nano-patterned CoCr surfaces 
on HUVECs adhesion, the number and spreading of adhered HUVECs after 
overnight incubation was studied by quantifying the LDH activity (Figure III.10A) 
and by immunofluorescence (Figure III.10B and 10C). Cell number and cell area 
showed no significant differences between all the different surface conditions. 
Thus, DLIP technique did not affect cell adhesion, confirming the published 
results of Raimbault et al. 30 on laser modified surfaces. The fact that DLIP 
technique did not modify the nano-roughness of the surface and, consequently, 
did not affect protein adsorption could explain the similar adhesion and spreading 
of HUVEC on the patterned surfaces compared to plain ones. On the other hand, 
cell aspect ratio was clearly affected by the depth of the patterning. H-patterned 
surfaces increased HUVECs elongation since a significantly higher aspect 
ratio (≥ 2.6 ± 0.5) was obtained compared to CTR (1.9 ± 0.2), whereas, 
L-structures showed no significant differences compared to CTR. Cell elongation 
is related with the number of HUVECs aligned onto the patterns lines finding a 
percentage ≥ 67.2 % for H-pattern series and < 36.0 % for CTR and L-pattern. 
Cells  were considered  aligned  if  the  angle  between  the  pattern  and  the cell 
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Figure III.10: HUVECs adhesion and spreading of CTR and patterned CoCr surfaces after 12h of 
cell culture. (A) Cell number quantified by means of LDH enzymatic assay. Columns with different 
letters belong to statistically different groups (p-value < 0.05). (B) Cells mean area, cells aspect 
ratio and % of aligned cells obtained by fluorescent microscopy. Images were analysed with FIJI 
software. Columns with different letters belong to statistically different groups (p-value < 0.05). 
(C) F-actin immunostaining of HUVECs on CTR and patterned CoCr surfaces. Black arrow indicates 
patterns direction. Scale bar = 100 μm. 
 
preferred direction was less than 30º. Fluorescence images for all conditions 
confirmed the differences in aspect ratio and number of aligned cells on 
H-pattern, whereas, L-pattern surfaces presented values similar to CTR. Thus, 
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despite changes in chemical properties on L-pattern surfaces generated by DLIP, 
no changes were detected in cell adhesion, spreading and alignment compared 
to CTR. Consequently, the elongation and alignment of HUVECs observed on 
H-pattern was attributed to the topographical pattern and to the associated 
anisotropic wettability. Biela et al. 4 reported similar conclusions showing in 
particular a higher cell elongation only on linear patterns deeper than 100 nm. 
Also, Dalby et al. demonstrated that cell filopodias can sense topography and act 
as a trigger for cells alignment onto patterned surfaces with depths down to 50 
nm 42. However, the origin of cells alignment on linear patterned surfaces remains 
controversial and Fujita et al. associated this cell behavior to a faster retraction 
of cell protrusions perpendicular to pattern direction compared to parallel ones 43. 
Also, SEM images (Figure III.11) showed HUVECs adhered randomly onto 
peaks and valleys of L- and H-pattern surfaces.  
 
Figure III.11: HUVECs adhesion and spreading on CoCr surfaces after 12h of incubation. SEM 
images of HUVECs on 10L and 10H surfaces. Scale bar = 40 μm. Upper images are secondary 
electron images, whereas lower images were obtained in backscatter electron mode. 
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3.2.3. Cell migration 
Cell migration was evaluated for CTR, 10L and 10H surfaces through the injury 
coverage ratio, which was defined as the percentage of injury area covered by 
HUVEC’s after 48 h (Figure III.12).  
 
Figure III.12: HUVECs migration on CTR, 10L and 10H surfaces at 0 h and 48 h timepoints. The 
percentage indicates the percentage of the respective initial injury area covered by HUVECs 
at 48 h.  Initial gap width = 500 ± 50 µm. Scale bar = 400 µm. 
 
After 48 h, it was detected significant differences in the migration of HUVECs onto 
studied surfaces. CTR and 10L series obtained similar values of cell migration 
with 42 % and 40 %, respectively, suggesting that L-pattern did not have any 
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effect on HUVECs migration. This result is in agreement with HUVECs adhesion 
assay where L-pattern surfaces did not have influence on HUVECs adhesion, 
elongation and alignment due to the negligible micro-roughness of the surface. 
On the contrary, 10H presented a value of 98% of recovery, indicating an 
accelerated HUVECs migration due to the pattern topography which enhances 
HUVECs alignment. Many studies have demonstrated that elongation and 
alignment of ECs are generally associated with a faster cell migration 4,44–46. 
Consequently, CoCr H-pattern surfaces seem to be a promising surface to 
enhance ECs migration from the healthy artery at the extremities of the stent and 
a possible candidate to recover a functional endothelium.  
To conclude, H-pattern series presented, on one side, topographic patterning, 
which induces HUVECs elongation, alignment and migration; and, on the other 
side, chemical modification, which generates low platelet adhesion and 
aggregation. Consequently, H-pattern CoCr surfaces obtained by DLIP technique 
could be used as a promising stent surface with a faster artery 
reendothelialization associated with a reduced platelet aggregation. 
 
4. Conclusions 
In this work, we reported a reliable and flexible one-step protocol to, 
simultaneously, produce a linear pattern and modify the oxide layer properties 
onto metallic surfaces with the capacity to influence ECs adhesion, alignment and 
migration as well as platelet adhesion and agglomeration. The DLIP technique 
allowed us to obtain topographical patterned CoCr surfaces with different 
periodicities and depths by modifying laser fluency. As a consequence of the very 
high temperature generated during DLIP, the initial crystalline oxide layer was 
modified to a thicker amorphous oxide layer more hydrophobic. The L-pattern 
series presented negligible topographical modification whereas the H-pattern 
series presented significant topographical pattern. While the L-pattern series did 
not show a significant effect on HUVECs response, H-pattern series induced 
HUVECs elongation, alignment and migration due to the topographical pattern. 
All patterned surfaces reduced platelet adhesion compared to plain CoCr 
surfaces which indicated that oxide layer structure transformation affected 
surface thrombogenicity. DLIP H-pattern series with an adequate combination of 
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topographic and chemical features can influence ECs and platelets response and 
could be a promising approach to accelerate endothelium recovery and avoid 
surface thrombosis. 
  
Chapter III  
 
74 
 
 References  
 
 
(1)  Roitero, E.; Lasserre, F.; Anglada, M.; Mücklich, F.; Jiménez-Piqué, E. A Parametric 
Study of Laser Interference Surface Patterning of Dental Zirconia: Effects of Laser 
Parameters on Topography and Surface Quality. Dent. Mater. 2016, 10–14. 
(2)  Günther, D.; Scharnweber, D.; Hess, R.; Wolf-Brandstetter, C.; Grosse Holthaus, 
M.; Lasagni, A. F. 1 – High Precision Patterning of Biomaterials Using the Direct 
Laser Interference Patterning Technology. In Laser Surface Modification of 
Biomaterials; 2016; pp 3–33. 
(3)  Fayou Yu, Frank Mucklich, Ping Li, Hao Shen, S. M.; Claus-Michael Lehr,  and U. B. 
In Vitro Cell Response to a Polymer Surface Micropatterned by Laser Interference 
Lithography. Biomacromolecules 2005, 6, 1160–1167. 
(4)  Biela, S. a; Su, Y.; Spatz, J. P.; Kemkemer, R. Different Sensitivity of Human 
Endothelial Cells, Smooth Muscle Cells and Fibroblasts to Topography in the 
Nano-Micro Range. Acta Biomater. 2009, 5 (7), 2460–2466. 
(5)  Palmaz, J. C.; Benson, A.; Sprague, E. A. Influence of Surface Topography on 
Endothelialization of Intravascular Metallic Material. J. Vasc. Interv. Radiol. 1999, 
10 (4), 439–444. 
(6)  Castellanos, M. I.; Mas-Moruno, C.; Grau, A.; Serra-Picamal, X.; Trepat, X.; 
Albericio, F.; Joner, M.; Manero, J. M.; Pegueroles, M. Functionalization of CoCr 
Surfaces with Cell Adhesive Peptides to Promote HUVECs Adhesion and 
Proliferation. Appl. Surf. Sci. 2016, 393, 82–92. 
(7)  Liu, H.; Pan, C.; Zhou, S.; Li, J.; Huang, N.; Dong, L. Improving Hemocompatibility 
and Accelerating Endothelialization of Vascular Stents by a Copper-Titanium Film. 
Mater. Sci. Eng. C 2016, 69, 1175–1182. 
(8)  Heng, B. C.; Bezerra, P. P.; Meng, Q. R.; Chin, D. W.-L.; Koh, L. B.; Li, H.; Zhang, H.; 
Preiser, P. R.; Boey, F. Y.-C.; Venkatraman, S. S. Adhesion, Proliferation, and Gene 
Expression Profile of Human Umbilical Vein Endothelial Cells Cultured on 
Bilayered Polyelectrolyte Coatings Composed of Glycosaminoglycans. 
Biointerphases 2010, 5 (3), 53–62. 
(9)  Andukuri, A.; Minor, W. P.; Kushwaha, M.; Anderson, J. M.; Jun, H.-W. Effect of 
Chapter III 
 75 
Endothelium Mimicking Self-Assembled Nanomatrices on Cell Adhesion and 
Spreading of Human Endothelial Cells and Smooth Muscle Cells. Nanomedicine 
2010, 6 (2), 289–297. 
(10)  Mucklich, F.; Lasagni, A.; Daniel, C. Laser Interference Metallurgy – Using 
Interference as a Tool for Micro/nano Structuring. Int. J. Mater. Res 2006, 97, 
1337–1344. 
(11)  Muggli, R.; Baumgartner, H. R.; Tschopp, T. B. Automated Microdensitometry and 
Protein Assays as a Measure for Platelet Adhesion and Aggregation on Collagen-
Coated Slides under Controlled Flow Conditions. J. Lab. Clin. Med. 1980. 
(12)  Sakariassen, K. S.; Aarts, P. A.; de Groot, P. G.; Houdijk, W. P.; Sixma, J. J. A 
Perfusion Chamber Developed to Investigate Platelet Interaction in Flowing Blood 
with Human Vessel Wall Cells, Their Extracellular Matrix, and Purified 
Components. J. Lab. Clin. Med. 1983, 102 (4), 522–535. 
(13)  Arderiu, G.; Díaz-Ricart, M.; Buckley, B.; Escolar, G.; Ordinas, A.; Arderiu; G; Diaz-
Ricart; M; B. Primary Arrest of Circulating Platelets on Collagen Involves 
Phosphorylation of Syk, Cortactin and Focal Adhesion Kinase: Studies under Flow 
Conditions. Biochem. J. 2002, 364 (Pt 1), 65–71. 
(14)  Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch, T.; 
Preibisch, S.; Rueden, C.; Saalfeld, S.; Schmid, B.; Tinevez, J.-Y. J.-Y.; White, D. J.; 
Hartenstein, V.; Eliceiri, K.; Tomancak, P.; Cardona, A.; Liceiri, K.; Tomancak, P.; 
A., C. Fiji: An Open Source Platform for Biological Image Analysis. Nat. Methods 
2012, 9 (7), 676–682. 
(15)  Park, J. Y.; Gemmell, C. H.; Davies, J. E. Platelet Interactions with Titanium: 
Modulation of Platelet Activity by Surface Topography. Biomaterials 2001, 22 
(19), 2671–2682. 
(16)  Hecker, J. F.; Scandrett, L. A. Roughness and Thrombogenicity of the Outer 
Surfaces of Intravascular Catheters. J. Biomed. Mater. Res. 1985, 19 (4), 381–395. 
(17)  Pries,  a R.; Secomb, T. W.; Gaehtgens, P. The Endothelial Surface Layer. Pflugers 
Arch. 2000, 440 (5), 653–666. 
(18)  Kuwahara, M.; Sugimoto, M.; Tsuji, S.; Matsui, H.; Mizuno, T.; Miyata, S.; 
Yoshioka, A. Platelet Shape Changes and Adhesion under High Shear Flow. 
Arterioscler. Thromb. Vasc. Biol. 2002, 22 (2), 329–334. 
Chapter III  
 
76 
 
(19)  von Allmen, M.; Blatter, A. Laser-Beam Interactions with Materials. Physical 
Principles and Applications, Springer S.; 1995. 
(20)  Hans, M.; Müller, F.; Grandthyll, S.; Hüfner, S.; Mücklich, F. Applied Surface 
Science Anisotropic Wetting of Copper Alloys Induced by One-Step Laser Micro-
Patterning. 2012, 263, 416–422. 
(21)  Fowler, D. E.; Rogozik, J.; David E. Fowler and Juergen Rogozik. Oxidation of a 
Cobalt Chromium Alloy: An X-Ray Photoemission Spectroscopy Study. J. Vac. Sci. 
Technol. A 1988, 6 (3), 928. 
(22)  Hagelin-Weaver, H. A. E.; Hoflund, G. B.; Minahan, D. M.; Salaita, G. N. Electron 
Energy Loss Spectroscopic Investigation of Co Metal, CoO, and Co3O4 before and 
after Ar+ Bombardment. Appl. Surf. Sci. 2004, 235 (4), 420–448. 
(23)  Tan, Y. L.; Gao, Q. M.; Yang, C. X.; Yang, K.; Tian, W. Q.; Zhu, L. H. One-Dimensional 
Porous Nanofibers of Co3O4 on the Carbon Matrix from Human Hair with 
Superior Lithium Ion Storage Performance. Sci Rep 2015, 5 (February), 15–17. 
(24)  Jiang, J.; Li, L. Synthesis of Sphere-like Co3O4 Nanocrystals via a Simple Polyol 
Route. Mater. Lett. 2007, 61 (27), 4894–4896. 
(25)  Jakubek, T.; Kaspera, W.; Legutko, P.; Stelmachowski, P.; Kotarba, A. Surface 
versus Bulk Alkali Promotion of Cobalt-Oxide Catalyst in Soot Oxidation. Catal. 
Commun. 2015, 71 (August), 37–41. 
(26)  Sousa, P. M.; Silvestre, A. J.; Popovici, N.; Conde, O. Morphological and Structural 
Characterization of CrO 2 / Cr 2 O 3 Films Grown by Laser-CVD. 2005, 247, 423–
428. 
(27)  Shim, S.-H.; Duffy, T. S.; Jeanloz, R.; Yoo, C.-S.; Iota, V. Raman Spectroscopy and 
X-Ray Diffraction of Phase Transitions in Cr2O3 to 61 GPa. Phys. Rev. B 2004, 69 
(14), 144107. 
(28)  Lasagni,  a.; Mücklich, F. FEM Simulation of Periodical Local Heating Caused by 
Laser Interference Metallurgy. J. Mater. Process. Technol. 2009, 209 (1), 202–209. 
(29)  Kern, T.; Yang, Y.; Glover, R.; Ong, J. L. Effect of Heat-Treated Titanium Surfaces 
on Protein Adsorption and Osteoblast Precursor Cell Initial Attachment. Implant 
Dent. 2005, 14 (1), 70–76. 
(30)  Raimbault, O.; Benayoun, S.; Anselme, K.; Mauclair, C.; Bourgade, T.; Kietzig, A. 
M.; Girard-Lauriault, P. L.; Valette, S.; Donnet, C. The Effects of Femtosecond 
Chapter III 
 77 
Laser-Textured Ti-6Al-4V on Wettability and Cell Response. Mater. Sci. Eng. C 
2016, 69, 311–320. 
(31)  Pegueroles, M.; Aparicio, C.; Bosio, M.; Engel, E.; Gil, F. J.; Planell, J. A.; Altankov, 
G. Spatial Organization of Osteoblast Fibronectin Matrix on Titanium Surfaces: 
Effects of Roughness, Chemical Heterogeneity and Surface Energy. Acta 
Biomater. 2010, 6 (1), 291–301. 
(32)  Milleret, V.; Hefti, T.; Hall, H.; Vogel, V.; Eberli, D. Influence of the Fiber Diameter 
and Surface Roughness of Electrospun Vascular Grafts on Blood Activation. Acta 
Biomater. 2012, 8 (12), 4349–4356. 
(33)  Hecker, J. F.; Edwards, R. O. Effects of Roughness on the Thrombogenicity of a 
Plastic. J. Biomed. Mater. Res. 1981, 15 (1), 1–7. 
(34)  Milleret, V.; Ziogas, A.; Buzzi, S.; Heuberger, R.; Zucker, A.; Ehrbar, M. Effect of 
Oxide Layer Modification of CoCr Stent Alloys on Blood Activation and Endothelial 
Behavior. J. Biomed. Mater. Res. - Part B Appl. Biomater. 2015, 103 (3), 629–640. 
(35)  Huang, N.; Chen, Y. R.; Luo, J. M.; Yi, J.; Lu, R.; Xiao, J.; Xue, Z. N.; Liu, X. H. In Vitro 
Investigation of Blood Compatibility of Ti with Oxide Layers of Rutile Structure. J 
Biomater Appl 1994, 8 (4), 404–412. 
(36)  Milleret, V.; Buzzi, S.; Gehrig, P.; Ziogas, A.; Grossmann, J.; Schilcher, K.; 
Zinkernagel, A. S.; Zucker, A.; Ehrbar, M. Protein Adsorption Steers Blood Contact 
Activation on Engineered Cobalt Chromium Alloy Oxide Layers. Acta Biomater. 
2015, 24, 343–351. 
(37)  Nan, H.; Ping, Y.; Xuan, C.; Yongxang, L.; Xiaolan, Z.; Guangjun, C.; Zihong, Z.; Feng, 
Z.; Yuanru, C.; Xianghuai, L.; Tingfei, X. Blood Compatibility of Amorphous 
Titanium Oxide Films Synthesized by Ion Beam Enhanced Deposition. 1998, 19, 
771–776. 
(38)  Maitz, M. F.; Tsyganov, I.; Pham, M.-T.; Wieser, E. Blood Compatibility of Titanium 
Oxides with Various Crystal Structure and Element Doping. J Biomater Appl 2003, 
17 (4), 303–320. 
(39)  Takemoto, S.; Yamamoto, T.; Tsuru, K.; Hayakawa, S.; Osaka, A.; Takashima, S. 
Platelet Adhesion on Titanium Oxide Gels: Effect of Surface Oxidation. 
Biomaterials 2004, 25 (17), 3485–3492. 
(40)  Chen, L.; Liu, M.; Bai, H.; Chen, P.; Xia, F.; Han, D. Antiplatelet and Thermally 
Chapter III  
 
78 
 
Responsive Poly ( N -Isopropylacrylamide ) Surface with Nanoscale. 2009, No. 18, 
10467–10472. 
(41)  Sun, T.; Tan, H.; Han, D.; Fu, Q.; Jiang, L. No Platelet Can Adhere-Largely Improved 
Blood Compatibility on Nanostructured Superhydrophobic Surfaces. Small 2005, 
1 (10), 959–963. 
(42)  Dalby, M. J.; Gadegaard, N.; Riehle, M. O.; Wilkinson, C. D. W.; Curtis, A. S. G. 
Investigating Filopodia Sensing Using Arrays of Defined Nano-Pits down to 35 Nm 
Diameter in Size. Int. J. Biochem. Cell Biol. 2004, 36 (10), 2015–2025. 
(43)  Fujita, S.; Ohshima, M.; Iwata, H. Time-Lapse Observation of Cell Alignment on 
Nanogrooved Patterns. J. R. Soc. Interface 2009, 6 (Suppl 3), S269-77. 
(44)  Song, K. H.; Kwon, K. W.; Song, S.; Suh, K.-Y.; Doh, J. Dynamics of T Cells on 
Endothelial Layers Aligned by Nanostructured Surfaces. Biomaterials 2012, 33 (7), 
2007–2015. 
(45)  Teichmann, J.; Morgenstern, A.; Seebach, J.; Schnittler, H.-J.; Werner, C.; Pompe, 
T. The Control of Endothelial Cell Adhesion and Migration by Shear Stress and 
Matrix-Substrate Anchorage. Biomaterials 2012, 33 (7), 1959–1969. 
(46)  Bouta, E. M.; McCarthy, C. W.; Keim, A.; Wang, H. B.; Gilbert, R. J.; Goldman, J. 
Biomaterial Guides for Lymphatic Endothelial Cell Alignment and Migration. Acta 
Biomater. 2011, 7 (3), 1104–1113. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter III 
 79 
 
Chapter IV  
 
80 
 
 
  
Chapter IV 
 81 
 
 
Chapter IV: Synergistic effect of surface 
biofunctionalization and nanopatterning of 
CoCr alloy for cardiovascular 
applications: endothelial cell adhesion, 
migration and proliferation 
 
  
Chapter IV  
 
82 
 
 
1. Introduction 
At the artery, endothelialization is mainly achieved through ECs migration from 
the healthy endothelium situated at both extremities of the stent. Different 
approaches have tried to modify the stent topography with a linear patterning in 
order to mimic the orientation of ECs at the coronary artery lumen 1–5. A large 
number of techniques have been applied to modify the surface topography of 
cardiovascular implants: metallographic grinding, plasma etching, 
photolithographic etching, and UV lithography, among others 6–9. However, most 
of the mentioned processing techniques involve multiple steps of preparation 
and, sometimes, including coatings steps. On the contrary, direct laser 
interference patterning (DLIP) requires only one single processing step and it can 
be applied to a wide range of materials 10. In Chapter III, we demonstrated that 
600 nm depth linear patterns obtained by DLIP on CoCr alloy surfaces induced 
the alignment and migration of ECs. Moreover, by modifying the chemical 
properties of these surfaces, DLIP technique induced a beneficial reduction of 
platelet adhesion.  
Within this context, the aim of this chapter is to modify CoCr alloy surfaces with 
a combination of linear patterning obtained by DLIP and bio-functionalization with 
RGD and YIGSR peptides to study the synergistic effect of both treatments in 
ECs adhesion, migration and proliferation. Linear patterned CoCr surfaces were 
characterized topographically by atomic force microscopy (AFM) and 
electrochemical assays were applied to determine the corrosion resistance 
properties. RGD and YIGSR peptides were covalently immobilized by silanization 
and the obtained coating characterized by Fourier transform infrared 
spectroscopy (FTIR), X-ray photoelectron microscopy (XPS), AFM and 
fluorescence microscopy.  Finally, the effect of surface modifications on the 
biological response was evaluated by ECs adhesion, migration and proliferation 
on the patterned and biofunctionalized surfaces. 
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2. Materials and methods 
2.1. CoCr alloy surfaces 
CoCr alloy ASTM F90 was polished and cleaned as explained in Chapter III 
section 2.1. to obtain smooth mirror-like surfaces (Ra < 10 nm). 
2.2. DLIP technique 
A Nd:YAG laser was used to modify the CoCr surfaces topography in conditions 
similar to Chapter III section 2.2. As a difference, the angle 2α between the two 
laser beams was fixe. As a result, the laser beams interfere onto the sample 
surface and generate a line-like interference pattern with a fixe periodicity (P) of 
10 µm (Figure IV.1). Laser fluency was varied to generate different pattern 
depths (D). A 0.81 J.cm-2 fluence was used to obtain low depth pattern (coded 
as 10L with D < 100 nm) and a 2.42 J.cm-2 fluence was used to obtain high depth 
pattern (coded as 10H with D > 700 nm). FLAT samples referred to polished and 
non-patterned ones. 
2.3. Functionalization of CoCr surfaces 
2.3.1. Solid-phase peptide synthesis 
The linear peptides RGDS and YIGSR were synthesized in solid-phase following 
the Fmoc/tBu strategy using Fmoc-Rink amide 4-methylbenzhydrylamine (MBHA 
resin) as solid support (300 mg, loading of 1.0 mmol/g), according to previously 
reported methods 11. The two functional sequences were synthesized containing 
three 6-aminohexanoic acid (Ahx) units as spacer system and two lysines (Lys), 
which served as anchors (Figure IV.1A). Moreover, the two peptides were 
synthesized with an additional 5(6)-carboxyfluorescein (CF) at their N-termini for 
characterization with fluorescence microscopy. The peptides were purified by 
semi-preparative HPLC (Waters, Milford, MA, USA) (XBridge C18 column, 19 x 
150 mm, 5 μm) and characterized by analytical HPLC (Waters) (XBridge C18 
column, 4.6 x 100 mm, 3.5 μm) and MALDI-TOF Voyager DE RP spectrometer 
(Applied Biosystems, Foster City, CA, USA). The characterization of the purified 
peptides is shown in Table IV.1. All chemicals required for the synthesis, 
including resins, Fmoc-L-amino acids and coupling reagents, were obtained from 
Iris Biotech GmbH (Germany) and Sigma-Aldrich (USA). 
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Figure IV.1: (A) Chemical structure of RGD and YIGSR peptides. Green: anchoring sequence 
(Lys-Lys); Red: spacer units (Ahx-Ahx-Ahx); Blue: functional sequences (Arg-Gly-Asp-Ser and 
Tyr-Ile-Gly-Ser-Arg) (B) Scheme of the DLIP and biofunctionalization steps to obtain the different 
patterned and/or biofunctionalized CoCr surfaces (FLAT: polished CoCr; 10L: low depth linear 
patterned CoCr surfaces; 10H: high depth linear patterned CoCr surfaces;  FLAT-CPTES, 
10L-CPTES and 10H-CPTES: FLAT, 10L and 10H followed by CPTES silanization; FLAT-RGD, 
10L-RGD and 10H-RGD: FLAT, 10L and 10H followed by CPTES silanization and 
biofunctionalization with RGD; FLAT-YIGSR, 10L-YIGSR and 10H-YIGSR: FLAT, 10L and 10H 
followed by CPTES silanization and biofunctionalization with YIGSR). 
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Table IV.1: RGD, RGD-CF, YIGSR and YIGSR-CF peptides sequences, retention time (tR), purity and 
molecular masse (m/z) obtained by analytical HPLC and MALDI-TOF. 
Code Sequence 
tR 
(min)a 
Purity 
(%)a 
Calculated 
m/z 
Experimental 
m/zd 
[M+H]+ 
RGD  Lys-Lys-(Ahx)3-Ser-Asp-Gly-Arg-OH 2.955b 93 1069.66 1069.68 
RGD CF Lys-Lys-(Ahx)3-Ser-Asp-Gly-Arg-CF 4.345b 98 1385.70 1385.66 
YIGSR Lys-Lys-(Ahx)3-Arg-Ser-Gly-Ile-Tyr-OH 5.228c 98 1230.78 1230.75 
YIGSR CF Lys-Lys-(Ahx)3-Arg-Ser-Gly-Ile-Tyr-CF 5.503c 99 1546.82 1546.80 
a) Retention time (tR) and purity were calculated by analytical HPLC using a reversed-phase 
XBridge BEH130 C-18 column (4.6 mm x 100 mm, 3.5 µm) (Waters, Milford, MA, USA) and a 
photodiode array detector (Waters 2998). b) Linear gradient: 0 to 60 % MeCN over 8 min; flow: 
1.0 mL/min. c) Linear gradient: 5 to 100 % MeCN over 8 min; flow: 1.0 mL/min. d) Mass spectra 
were recorded on a MALDI-TOF Voyager DE RP spectrometer (Applied Biosystems, Foster City, 
CA,USA). 
 
2.3.2. Protocol of immobilization 
The peptides were covalently immobilized on the CoCr surfaces through a three-
step strategy consisting of activation, silanization and peptide immobilization 
(Figure IV.1B). 
First, surfaces were activated with 5 M NaOH solution during 2 h at room 
temperature (RT) under ultrasonication to generate hydroxyl groups. Treated 
samples were then cleaned twice in distilled water under ultrasonication for 
30 min. Afterwards, activated samples were silanized in 10 ml solution of 0.5 M 
3-chloropropyltriethoxysilane (CPTES) (Sigma-Aldrich) and 0.05 M 
N,N-diisopropylethylamine (DIEA) in anhydrous toluene at 90 °C for 1 h under 
nitrogen atmosphere and vigorous stirring. Silanized samples were ultrasonically 
rinsed in cyclohexane, isopropanol, Milli-Q distilled water and acetone for 15 min 
each, and finally dried with nitrogen. Silanized samples were coded as 
FLAT-CPTES, 10L-CPTES and 10H-CPTES. Finally, silanized samples were 
immersed overnight in 100 µM peptide solutions (samples coded as FLAT-RGD, 
10L-RGD, 10H-RGD, FLAT-YIGSR, 10L-YIGSR and 10H-YIGSR) in phosphate-
buffered saline (PBS) with a pH 10.0 at RT and washed three times with distilled 
water. 
2.4. Physico-chemical characterization of the patterned surfaces 
Surface morphology and roughness of CoCr samples were analyzed by atomic 
force microscopy (AFM) (Dimension 3100, Veeco Digital Instruments, Bruker, 
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Germany). Topographic, error signal mode, and phases images were recorded 
simultaneously in tapping-mode in air using a silicon Tap150al-G cantilever 
(NanoWorld Group, Neuchâtel, Switzerland) at a scan rate of 1 Hz. Five areas of 
50x50 µm2 were analyzed for FLAT, 10L and 10H CoCr surfaces. Obtained 
images were studied by WSxM software 12. The topographical profile as well as 
the root mean square roughness (Rq) were obtained from topographic images: 
Rq-micro from areas of 50x50 µm2 and Rq-nano from areas of 1x1 µm2. 
To evaluate the effect of surface modification with the DLIP technique on the 
corrosion of CoCr alloy surfaces, electrochemical characterization was performed 
with a potentiostat PARSTAT 2273 (Princeton Applied Research, USA) with a 
Faraday cage. Measurements were controlled with the software PowerSuite 
Electrochemical (Princeton Applied Research). A saturated calomel electrode 
(SCE, Koslow Scientific Company, USA) was used as reference electrode and a 
Hank’s balanced salt solution (Sigma-Aldrich) was used as electrolyte solution. 
Open circuit potential assays were done following the standard ISO 10993-15 13 
in order to determine the corrosion potential of patterned CoCr surfaces. 
Degradation products of FLAT and patterned CoCr samples were evaluated after 
immersion in the Hank's balanced salt solution at 37 ºC during seven days. 
Released ions to the medium were measured by mass spectroscopy ICP-MS 
(Agilent 7500CE, USA) as indicated by the standard ISO 10993-15. 
A streaming potential instrument (Surpass Electrokinetic Analyzer, Anton Paar, 
Austria) with an adjustable gap cell was used to obtain the zeta-potential of FLAT, 
10L and 10H surfaces. Measurements were performed with a 1 mM KCl solution 
as electrolyte and the pressure ramp run up to a maximum pressure of 400 mbar. 
The initial electrolyte solution was adjusted to pH 9.0 using 0.1 M KOH solution 
and titrated by adding 0.1 M HCl down to pH 3.0. The isoelectric point (IEP) and 
the surface charge at pH 7.4 were obtained using the VisioLab software (Anton 
Paar). 
2.5. Physico-chemical characterization of the biofunctionalized surfaces 
Silanized and biofunctionalized CoCr surfaces were chemically characterized 
with attenuated total reflectance Fourier transform infrared (ATR-FTIR) 
spectroscopy using a Nicolet 6700 FTIR spectrometer (Thermo Fisher Scientific, 
USA) combined with the ATR Smart Saga furnished with a diamond crystal. 
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Sampling area was set to a 1 mm diameter circle, scan resolution was 0.482 cm-1 
and each sample analysis was the result of the average of 512 scans. All samples 
spectra were analysed with OMNIC 8 software (Thermo Fisher Scientific).  
To characterize the silane and peptides layers, FLAT and biofunctionalized CoCr 
surfaces were analyzed by AFM. AFM conditions were similar to the previously 
described at Chapter IV section 2.4. Only the scanning velocity and area were 
changed to 0.5 Hz and 2x2 µm2, respectively. Topographical profile and 
roughness Rq-nano were obtained from height images. Phase images were used 
to extract the phases distribution and calculate the percentage of area covered 
by non-metallic substances. 
X-ray photoelectron spectroscopy (XPS) was used to analyse chemical 
composition of CoCr surfaces before and after functionalization. Measurements 
were performed with a SPECS Surface Nano Analysis GmbH (Berlin, Germany) 
equipped with a Mg anode X50 source operating at 150 W and a Phoibos 150 
MCD-9 detector. The elements present on the surface were evaluated by 
low-resolution survey spectra, whereas high-resolution of some elements (C 1s, 
O 1s, Cr 2p, Co 2p, N 1s and Cl 2p) were measured with a pass energy of 25 eV 
at 0.1 eV steps at a pressure below 7.5 × 10-9 mbar. All binding energies were 
referred to the C1s signal at 284.8 eV. Casa XPS software (Version 2.3.16, Casa 
Software Ltd., Teignmouth, UK) was used to do fitting and peak integration of 
spectra. 
The stability of the peptide layer toward sterilization and ultrasonication 
treatments was analysed by fluorescence. To this end, samples were 
functionalized with fluorescent peptides RGD-CF and YIGSR-CF, and 
subsequently subjected to either sterilization by gamma radiation (AragoGamma, 
Spain) using a 25 kGy dose (samples FLAT-RGD-RG and FLAT-YIGSR-RG) or 
ultrasonication during 1h in PBS (samples FLAT-RGD-US and FLAT-YIGSR-
US). Then, the fluorescent immobilized peptides before and after stability 
treatments were extracted with 500 µl of 0.2 M NaOH during 2 h at RT 14. The 
fluorescence of the extracted solution was measured with a 
spectrofluorophotometer (Infinite M200 PRO NanoQuant Microplate reader, 
Tecan, Switzerland) at 492 nm excitation and 517 nm emission wavelengths. The 
quantity of attached peptides was determined by comparison with a standard 
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curve, which was prepared under identical conditions with peptides concentration 
ranging from 0 up to 1000 ngml-1. 
2.6. Biological characterization 
2.6.1. Endothelial cells 
Cellular experiments were conducted using HUVECs in the exact same 
conditions as in Chapter III (section 2.1.). All cellular studies were done using 
triplicates and repeated at least in two independent assays to ensure 
reproducibility. 
2.6.2. Cell adhesion 
Previous to cell adhesion assay, CoCr samples were sterilised in ethanol 70% for 
20 min at RT. Next, samples were placed in 48-well plates and 30,000 cells/disk 
were seeded and allowed to attach in serum free medium. Samples were 
incubated overnight at 37 °C and rinsed thrice with PBS to remove non-adherent 
cells. To characterize the number and spreading of adhered HUVECs, nuclei and 
actin fibers were stained by immunofluorescence following the protocol explained 
in Chapter III section 2.4.2. Cell number and morphology parameters were 
studied by FIJI software 15 obtaining the cell number, cell mean area, and 
percentage of aligned cells for each surface. Cells were considered aligned if the 
angle between the long axis and the pattern was < 30°. Once analysed, CoCr 
samples were ultrasonically cleaned in PBS and adhered cells were fixed with 
glutaraldehyde (G400-4, Sigma-Aldrich) and dehydrated through immersion in 
different solutions of ethanol in order to observe in more detail the cells shape by 
field emission scanning electron microscopy (FE-SEM) with a Zeiss Neon40 FE-
SEM microscope (Carl Zeiss NTS GmbH, Germany). For each sample, five 
images were taken at a working distance of 6 mm and a potential of 5 kV.  
2.6.3. Wound healing migration study 
To evaluate the process of wound healing and cell migration onto patterned and 
functionalized CoCr surfaces, HUVECs were stained with the cell membrane 
fluorescent linker PKH67 (PKH67-GL, Sigma-Aldrich) 24 h prior to wound healing 
assays. Before cell culture, CoCr samples were sterilized in ethanol 70% for 20 
min at RT. The wound healing processes were reproduced by placing an Ibidi 
culture-insert (Ibidi, Germany) on top of each sample. On the patterned surfaces 
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the Ibidi insert was placed keeping the gap perpendicular to the patterns lines. 
Thus, a suspension of 20,000 labeled cells were placed at both chambers of the 
insert with complete medium, and incubated for 24 h until reaching a confluent 
HUVEC adhesion. After, the insert was removed creating a cell-free gap of 
500 ± 50 µm. The surfaces were cleaned twice with PBS to remove non-adhered 
cells and then, filled with serum free medium. HUVEC cell migration was recorded 
using a fluorescence stereomicroscope (Leica MZ16F, Leica microsystems, 
Germany) combined with the camera DFC 300 FX (Leica Microsystems). Gap 
images were acquired for all the samples at 0 h and 24 h. The non-covered area 
for each CoCr disk was calculated with FIJI software and the percentage of 
recovery was calculated for each series. 
2.6.4. Cells proliferation 
To study the proliferation of cells on the substrates, 10,000 HUVECs/well were 
plated on samples in serum-free medium and incubated as previously described 
for cell adhesion assays. 4 h post seeding, medium was aspired and replaced 
with complete medium. After 2, 5, and 8 days of incubation, cell number was 
evaluated with the Alamar Blue assay (Invitrogen Life Technologies, Merelbeke, 
Belgium). Briefly, Alamar Blue-containing medium (10% (v/v)) was added for 2 h, 
and fluorescence of the dye was quantified according to the manufacturer 
instructions with a multimode microplate reader (Infinite M200 PRO, Tecan 
GroupLtd., Männedorf, Switzerland). 
2.7. Statistical analysis  
Statistical significance between means was analyzed by ANOVA test followed by 
post-hoc pair-wise comparison using Tukey’s test at p ≤ 0.05 (Minitab 16.2.2 
Statistical Software, Minitab Inc.). All experiments data presented in this study 
are given as mean value ± standard deviations. 
 
3. Results and discussion 
3.1. Fabrication of linear patterned CoCr and surface characterization 
CoCr surfaces were topographically modified by DLIP technique. Linear patterns 
with a periodicity of 10 µm were obtained. Its size was slightly smaller than ECs 
nucleus, in order to induce ECs elongation and migration following the pattern 
Chapter IV  
 
90 
 
direction. Figure IV.2 and Table IV.2 summarize the measured topographical 
parameters directly measured by AFM. 
 
Figure IV.2: AFM analysis of 10L and 10H surfaces to characterize the patterns topographical 
properties. (A) AFM error signal mode images of 10L and 10H surfaces. Scale bar = 10 μm. 
(B) AFM topographical profiles of 10L and 10H surfaces in the direction perpendicular to the 
patterns lines. Dot line indicate the estimated initial surface. 
 
Table IV.2: Topographical parameters of the FLAT, 10L and 10H surfaces. Rq-micro is the root mean 
square roughness measured on a 50x50 µm2 area. Rq-nano is the root mean square roughness 
measured on a 1x1 µm2 area. 
 
Periodicity P Depth D Rq-micro  Rq-nano 
µm nm nm  nm 
FLAT - - 7 ± 1 - 0.66 ± 0.23 
10L 10.0 ± 0.1 79 ± 12 33 ± 4 
Valley 0.54 ± 0.17 
Peak 0.78 ± 0.31 
10H 10.0 ± 0.1 762 ± 83 304 ± 25 
Valley 0.79 ± 0.22 
Peak 0.79 ± 0.17 
 
Chapter IV 
 91 
By modifying the laser fluence, two different structures were obtained, low depth 
patterned 10L (D ≈ 79 nm) and high depth patterned 10H (D ≈ 762 nm) surfaces. 
As expected, the topographical modifications increased the micro-roughness, 
Rq-micro, of non-modified surfaces (FLAT) from 7.4 ± 1.3 nm up to 33.2 ± 3.7 nm 
for 10L surfaces and 303.6 ± 24.9 nm for 10H series. However, nano-roughness 
of FLAT samples and patterned surfaces, either at peaks or valleys, showed no 
statistical differences. AFM error signal mode images (Figure IV.2A) for the two 
different patterned surfaces confirmed that 10H surfaces presented homogenous 
grooves with clearly identifiable peaks and valleys; in contrast, on 10L surfaces 
the low depths hindered the identification of peaks compared to valleys. Figure 
IV.2B presents the cross-section profiles of 10L and 10H surfaces directly 
extracted from the AFM topographic images, which allowed characterizing the 
shape of the peaks. Indeed, 10H is characterized by a sinusoidal shape with 
valleys, where constructive interference occurs, and peaks, where destructive 
interference takes place and thus, two melted material fronts joint. On the 
contrary, 10L surfaces is composed of a low depth valley where the constructive 
interferences met creating two small peaks at both sides and a non-modified flat 
area where the beams interacted destructively. These two different 
configurations, called respectively single and double-peak pattern surfaces, are 
usual for metallic surfaces modified by DLIP, as described in Chapter III and in 
previous studies 1,16. Such differences can be explained by the applied laser 
fluencies: high fluencies, used for 10H series, provided enough energy to melt a 
considerable amount of metal that flowed outside the constructive interference 
spots towards the destructive interference spots, due to the surface tension 
gradient resulting from the temperature gradient 16–18. At the destructive 
interference spots the advancing melt fronts join, creating the characteristic 
peaks. In the case of 10L series, the applied low fluence melted a lower quantity 
of CoCr alloy and the two fronts could not joint together, generating two small 
peaks surrounding the spots where the beams interfered constructively. In both 
surfaces, 10L and 10H, the high temperatures applied during DLIP transformed 
the crystalline oxide layer into a thicker amorphous oxide layer overall the 
surface, as demonstrated in the Chapter III. Thus, considering the low roughness 
of 10L surfaces, 10L series could be considered mainly as surfaces with chemical 
changes, and a negligible topographical pattern. 
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CoCr alloy ASTM F-90 is extensively used as stent material mainly due to its 
capacity of forming a naturally passive oxide layer that confers very good 
corrosion resistance properties to the material. As surface patterning by DLIP 
could generate changes in the corrosion behaviour of the materials, 
electrochemical assays and ion release tests were performed (Table IV.3). All 
studied series presented statistically equal corrosion potentials of approximately 
1000 mV, suggesting that DLIP did not modify the corrosion resistance of the 
CoCr surfaces. Moreover, no corrosion pits were observed on the tested surfaces 
(not shown), validating DLIP as a treatment that do not-modify the corrosion 
resistance observed in FLAT surfaces. Ion release assays were performed in 
Hank’s balanced salt solution at 37ºC during 7 days. The release of Ni ions, 
susceptible to allergy, was not significantly higher on 10L and 10H surfaces, 
compared to FLAT surface. The release of Co and Cr ions, on 10L surfaces was 
slightly lower than on FLAT, indicating that 10L series are not toxic just as the 
CoCr alloys used in the current stents. On the other hand, the release of ions 
significantly increased on 10H series (Cr: 4.3 ± 0.3 ng; Co: 77.8 ± 8.6 ng) 
compared to FLAT (Cr: 1.6 ± 0.3 ng; Co: 47.5 ± 16.0 ng). However, such higher 
release should not be detrimental for the biological performance of these 
materials. Firstly, the high toxicity and carcinogenic properties of Cr are 
associated to its hexavalent form (chromium VI) 19, and we have shown in 
Chapter III that DLIP generated only Cr (III) at the CoCr alloy oxide layer. 
Secondly, it should be taken into consideration that stents are placed in the artery 
and release metallic ions under blood flow conditions. Thus, if we consider 5 liters 
as the normal blood quantity for an adult and the stent surface area being half of 
the area of the studied samples, the release of Cr and Co from 10H surfaces 
would be equivalent to 4.3x10-4 ng/ml and 7.8x10-3 ng/ml, respectively. These 
values are 100,000 and 15,000 times lower, for Cr and Co, respectively, than the 
maximum concentrations recommended by the World Health Organization 
(Cr: 50 ng/ml; Co: 150 ng/ml) 20,21. Consequently, even if the released ions were 
increased on 10H series compared to FLAT, the release of metallic ions after 
DLIP patterning is kept at non-toxic levels. 
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Table IV.3: Detailed results of corrosion resistance, ion release and zeta potential on CoCr 
surfaces before and after DLIP patterning. Corrosion potential and ion release were obtained 
according to the standard ISO 10993-15. Isoelectric point (IEP) and zeta potential (ζ) at pH 7.4 
were measured. 
   Ion release  Zeta potential 
 
Corrosion potential  Co ions Cr ions Ni ions  IEP ζ at pH 7.4 
mV  ng ng ng  pH mV 
FLAT 1014.3 ± 10.1  47.5 ± 16.0 1.6 ± 0.3 12.4 ± 3.8  4.9 ± 0.0 - 34.5 ± 2.9 
10L 1017.6 ± 9.5 
 
23.3 ± 6.3 1.5 ± 0.2 9.4 ± 2.8 
 
4.8 ± 0.0 - 39.7 ± 0.2 
10H 1031.7 ± 6.1  77.8 ± 8.6 4.3 ± 0.3 17.5 ± 1.0  4.5 ± 0.0 - 11.5 ± 1.0 
 
The zeta potential studies indicated that the IEP of the FLAT and the patterned 
surfaces is around pH ~ 4.7. As the solution was more alkaline, the surfaces 
showed a steadily more negative zeta potential. The ζ at pH 7.4 is very similar on 
FLAT and 10L surfaces mainly because the roughness of 10L surfaces is 
negligible. For 10H surfaces it was found a less negative surfaces charge 
compared to FLAT due to the effect of the linear pattern. The effect of peaks and 
valleys onto zeta potential measurements have been already described 22. The 
fact that linear pattern retains charges inside the valleys prevents their detection 
at the end of the channel and possibly generates an opposite flow, leading to a 
decrease in measured zeta potential.  
3.2. Biofunctionalization of CoCr and surface characterization 
The studied peptides were synthesized with the structure and the characteristics 
presented in Figure IV.1 and Table IV.1. As previously mentioned, both peptides 
are composed of three distinct parts. First, the bioactive sequences, RGD and 
YIGSR (in blue in Figure IV.1), which determine the biological functionality of the 
biomolecule. The RGD sequence was chosen for its well-known effect on cell 
adhesion 23–26 and YIGSR was selected for its ability to bind specifically to ECs 
27–31. Secondly, the spacer units, three aminohexanoic acid (Ahx) (in red), which 
ensure the appropriate accessibility of the functional sequences to interact with 
cells. Indeed, in previous studies, it has been demonstrated that peptides with 
spacer molecules shorter in length failed to influence the biological activity on the 
coated surfaces 31,32. And finally, two lysines (in green) which contain primary 
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amines in their side chains as anchoring groups, to covalently attach the peptides 
to the silanized surface. 
The effectiveness of silanization and functionalization of CoCr surfaces was 
evaluated by ATR-FTIR (Figure IV.3), AFM (Figure IV.4) and XPS (Figure IV.5). 
ATR-FTIR spectra of FLAT-CPTES, FLAT-RGD and FLAT-YIGSR surfaces are 
presented in Figure IV.3.  
 
Figure IV.3: ATR-FTIR of FLAT-CPTES, FLAT-RGD and FLAT-YIGSR surfaces from 700 to 1600 cm-1. 
Arrows indicate significant peaks. 
 
On all the surfaces, the peak observed at 1267 cm-1, which corresponds to C = O 
bonding, was the result of atmospheric contamination. On CPTES samples, Si-
O-R peaks, at 1100 cm-1, were related to the covalent bonding of the silane on 
the surface 33,34. Also, the terminal chlorine group from the CPTES silanes was 
detected at a wavelength of 870 cm-1. Finally, as CoCr alloys did not contain CH3 
group, the CH3 peak, at 1430 cm-1, confirmed the presence of CPTES on FLAT-
CPTES surfaces. The spectra of RGD and YIGSR-coated surfaces displayed 
exactly the same peaks detected on CPTES samples. In particular, no N bonding 
peaks were detected, as it would be expected in the presence of peptides. This 
observation could be due to the low sensitivity of the surface technique, which 
would be not adequate to detect a low amount of biomolecule.  
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AFM characterization was done to analyze the layer of silane and peptides 
immobilized onto CoCr surfaces (Figure IV.4). As expected, FLAT surface 
showed a smooth surface with some scratches from polishing, while CPTES 
series presented small clusters of 6 nm height approximately (Figure IV.4A). 
Similar differences were observed by T. Sargeant et al. 35 after silanization on 
NiTi alloy surfaces. Moreover, FLAT-RGD, FLAT-YIGSR, 10L-CPTES and 
10H-CPTES surfaces presented roughness values very similar to those 
measured in the CPTES samples (Figure IV.4C). Indeed, all these five conditions 
had Rq-nano values of about 2.5 nm with no statistical differences; whereas FLAT 
samples presented values 4 times lower (Rq-nano = 0.66 ± 0.23 nm). The increment 
of the Rq-nano roughness for silanized and functionalized surfaces, compared to 
FLAT, can be thus attributed to the coating layer. Since no statistical differences 
were found between silanized and functionalized surfaces, we can assume that 
the peptide layer is very thin and not observable with AFM. Also, the similar 
roughness observed on FLAT and patterned silanized surfaces suggested that 
the efficiency of silanization is not affected by the DLIP process.  
Figure IV.4B exhibits the phase map for the region of interest. It is found a single 
phase for FLAT surfaces while CPTES series showed a bimodal phases 
distribution at -33º and 8º. AFM phase imaging in tapping mode is directly related 
to the viscoelastic properties of the analysed surface and, consequently, to the 
surface hardness of the material. Thus, CPTES surfaces seemed to have 
different materials properties, presumably related to the immobilization of silanes 
onto CoCr surface. Also, the percentage of covered area by the coating was 
calculated (Figure IV.4D). All functionalized surfaces presented an 85 % of 
surface coverage and no statistical differences were observed between silanized 
and functionalized surfaces onto both polished and patterned CoCr surfaces. 
The increased roughness and the presence of two different phases on 
FLAT-CPTES compared to FLAT confirmed the attachment of CPTES silane on 
the surface. Since the same results were observed on 10L-CPTES and 
10H-CPTES, we can conclude that the silanization process occurred with the 
same efficiency on FLAT and patterned surfaces. However, as FLAT-RGD and 
FLAT-YIGSR presented similar roughness and surface coverage than CPTES 
surfaces, we could not ascertain whether the peptides were present or not.  
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Figure IV.4: AFM analysis of FLAT, FLAT-CPTES, FLAT-RGD, FLAT-YIGSR, 10L-CPTES and 
10H-CPTES surfaces to characterize the silane and peptides layers. Scale bar = 500 nm. Columns 
marked with different letters belong to statistically different groups (p-value < 0.05). (A) AFM 
error signal mode images and topographical profiles of FLAT and CPTES surfaces. 
(B) Tapping-mode AFM phase images and phases distributions of FLAT and CPTES surfaces. 
(C) Roughness Rq-nano calculated from AFM height images. (D) % of area covered by the coating 
calculated from AFM phase images. 
 
 
To evaluate the presence of immobilized peptides onto functionalized surfaces, 
FLAT, FLAT-RGD and FLAT-YIGSR surfaces were characterized by XPS 
(Figure IV.5). Untreated CoCr alloys displayed characteristic peaks of C 1s, O 
1s, Co 2p and Cr 2p. The presence of carbon is attributed to atmospheric organic 
contaminants 36. A small amount of nitrogen (N 1s) and silicon (Si 2p) 
contaminations was also detected. On FLAT-RGD and FLAT-YIGSR surfaces 
the percentage of Si 2p was increased due to the presence of CPTES. 
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A significant increase in N 1s was also detected for functionalized surfaces 
compared to FLAT (FLAT: 0.66 ± 0.05 %; FLAT-RGD: 1.56 ± 0.28 %; 
FLAT-YIGSR: 1.53 ± 0.03 %). This presence of nitrogen was attributed to the 
amide groups and other amino functionalities characteristic of the peptide 
sequences 37, thereby confirming the attachment of the RGD and YIGSR 
peptides onto the surfaces. However, the fact that Cl 2p was detected as well 
after the functionalization indicates that not all the electrophilic points of CPTES 
(i.e. –CH2-Cl) reacted with the peptides. This observation suggests a limited 
coverage of the silane layer by the peptides, in agreement with the low % of N 1s 
quantified and FTIR data. Finally, it is worth to mention that no statistical 
differences were observed in N 1s, Si 2p and Cl 2p signals between FLAT-RGD 
and FLAT-YIGSR surfaces, suggesting that the functionalization occurred with 
the same effectiveness and the amount of immobilized peptides was very similar.  
 
Figure IV.5: Analysis of the chemical composition (atomic %) of FLAT, FLAT-RGD and FLAT-YIGSR 
surfaces by XPS. For Si 2p, N 1s and Cl 2p, bars designated with different letters belong to 
statistically different groups (p-value < 0.05). 
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To evaluate the stability of the covalent immobilization of the different peptides 
FLAT-RGD and FLAT-YIGSR surfaces were subjected to either gamma radiation 
sterilization or ultrasound sonication with MilliQ water (Figure IV.6). The amount 
of immobilized fluorescent peptide onto FLAT-RGD and FLAT-YIGSR was 
calculated before the stability treatments and was statistically the same, 
confirming the results observed with XPS. The amount of immobilized peptide 
slightly decreased for both peptides after the stability tests, although the 
percentages of peptide loss were very moderate and overall, 74% or more of the 
peptides remained on the surface (FLAT-RGD-RG: 95.2%; 
FLAT-RGD-US: 81.5%; FLAT-YIGSR-RG: 74.2% and 
FLAT-YIGSR-US: 75.7%). Ultrasonication represents an aggressive mechanical 
challenge and may remove physisorbed peptides attached through weak 
bonds 38.Gamma radiation could affect chemical covalent or weak bonding and, 
consequently, remove a piece or the entire peptide 39. It should be noted that the 
CF fluorescent molecule was coupled at the N-terminus of the peptide sequence, 
i.e. at the opposite of the anchoring regions of the C-terminus, thus, the detection 
of fluorescence after the RG sterilization indicates that more than 74 % of 
attached peptides remained entire. These results suggest that the majority of the 
peptide coatings are stable to RG sterilization and mechanical stress, which both 
occur during stent implantation. 
 
Figure IV.6: Quantification by indirect fluorescence of the amount of immobilized peptides onto 
FLAT and biofunctionalized surfaces before (FLAT-RGD and FLAT-YIGSR) and after sterilization 
with gamma radiation (FLAT-RGD-RG and FLAT-YIGSR-RG) or after ultrasound sonication 
(FLAT-RGD-US and FLAT-YIGSR-US). Bars designated with different letters belong to statistically 
different groups (p-value < 0.05). 
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3.1. HUVECs adhesion and alignment 
The number of adhered HUVECs onto modified CoCr surfaces was evaluated by 
fluorescent microscopy (Figure IV.7A). Polished and patterned non-
functionalized surfaces presented the same number of adherent cells, proving 
that the nanotopography, alone, did not influence HUVECs adhesion onto CoCr 
surfaces. Previous studies have reported higher cell adhesion on linear patterned 
surfaces with the same periodicity (i.e. around 10 µm) 3,8,40–42. However, the 
investigations on DLIP patterned surfaces described no changes in cell adhesion 
1,43, possibly as a result of the relatively low pattern depth (< 1 µm) introduced by 
this technique and the non-sharp shape of the patterns peaks. Differences in cell 
area were neither observed between FLAT and 10L surfaces. In contrast, this 
parameter was statistically reduced on 10H. The reason for such behavior 
probably relied on the effect of the peaks geometry that acted as a barrier for 
cellular spreading. Thus, we considered that high depth DLIP patterning had no 
effect on cell number but reduced slightly the spreading of attached HUVECs.  
On the contrary, surface functionalization with the peptides did not modify the cell 
mean area but significantly increased the number of attached HUVECs, with 
YIGSR functionalization yielding the highest values of cell adhesion. Indeed, onto 
RGD and YIGSR functionalized surfaces cell numbers increased approximately 
80% and 120%, respectively, compared to the non-functionalized surfaces. The 
observed increased amount of adhered cells for YIGSR, combined with the fact 
that this peptide sequence specifically targets ECs 27,29,44, indicates that CoCr 
functionalization with YIGSR peptides is a feasible way to promote ECs adhesion 
while avoiding the adhesion of SMCs or platelets 31. 
Next, HUVECs alignment was characterized by fluorescent staining of actin fibers 
(Figure IV.7A) and FE-SEM visualization (Figure IV.7B). A cell was considered 
aligned if the angle between the patterned lines and the longest segment of the 
cell was inferior to 30º. Consequently, a surface having no effect on the ECs 
orientation should present around 33% of aligned cells. HUVECs alignment was 
directly related to the pattern dimension. FLAT series and 10L-patterned series, 
functionalized or not, produced a percentage of HUVECs alignment between 31 
and 40 %, and thus had little impact on cellular alignment. The designed 
patterning of 10H surfaces, however, induced a remarkable alignment of 
HUVECs,   of   79 ± 7 %,   81 ± 12 %   and   75 ± 12 %   for 10H,  10H-RGD   and  
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Figure IV.7: HUVECs adhesion and spreading on FLAT, patterned or/and functionalized CoCr 
surfaces after 12 h of incubation. (A) Cell number, cells mean area and % of aligned cells were 
obtained by fluorescent microscopy. Images were analysed with FIJI software. Bars designated 
with different letters belong to statistically different groups (p-value < 0.05). (B) FE-SEM images 
of HUVECs on FLAT, 10H, FLAT-YIGSR and 10H-YIGSR surfaces. Scale bar = 30 μm. 
 
Chapter IV 
 101 
10H-YIGSR, respectively, without statistical differences within tem. Thus, 
10H series induced the alignment of HUVECs following the direction of the 
patterns and reduced HUVECs mean area due to the micro-level of the pattern. 
Patterns of 10L surfaces had grooves with a depth 10 times smaller than ECs 
thickness 45 and it is probable that they simply act as a pavement instead of a 
wall where the HUVECs can easily spread in all directions. 
 
3.2. HUVECs migration 
Cell migration was evaluated through the injury coverage ratio, which was defined 
as the percentage of injury area covered by HUVEC’s after 24 h (Figure IV.8).  
 
Figure IV.8: HUVECs migration on FLAT, patterned and/or functionalized CoCr surfaces at 0 h 
and 24 h timepoints. The percentage indicates the percentage of the respective initial injury area 
covered by HUVECs at 24 h.  Initial gap width = 500 ± 50 µm. Scale bar = 400 µm. 
 
The migration of HUVECs was observed on all CoCr surfaces. On non-
functionalized FLAT and 10L surfaces series injury recovery was of only 18 % 
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and 21 %, respectively, demonstrating that 10L patterns did not have an effect 
on HUVECs migration. On the contrary, 10H nanopatterns presented a higher 
value of 78% of recovery, indicating an accelerated migration, probably due the 
alignment produced by the patterned topography 3,40,46,47. When FLAT and 10L 
CoCr surfaces were functionalized with RGD and YIGSR peptides, HUVECs 
migration was significantly accelerated (more than 2-fold), with no differences 
detected between the two peptides. Noteworthy, the combination of 10H 
nanopatterns and functionalization with RGD and YIGSR peptides significantly 
improved HUVECs migration compared to all surfaces: 10H-RGD and 
10H-YIGSR surfaces presented an almost complete healing of 97 % and 98 %, 
respectively. This result proves that combining DLIP patterning and 
functionalization with RGD or YIGSR peptides, which increase HUVECs 
alignment and adhesion, respectively, synergistically accelerates HUVECs 
migration after 24 h. 
3.3. HUVECs proliferation 
The effect of DLIP and RGD and YIGSR functionalization on HUVECs 
proliferation was assessed by an Alamar blue assay after 2, 5 and 8 days of cell 
culture (Figure IV.9). As expected, HUVECs proliferation increased on all 
surfaces over time. After 2 days, cell number was significantly higher on all 
peptide-functionalized surfaces compared to non-functionalized FLAT, 10L and 
10H surfaces. After 5 and 8 days, this effect was emphasized. Also linear 
patterning had an effect and, at 5 and 8 days, a higher cell proliferation was 
observed on 10H series compared to the respective FLAT and 10L surfaces. This 
was probably induced by the faster cell migration observed on these 
nanopatterns. Indeed, when proliferating, cells have less space and are in close 
contact with other cells. Consequently, due the effect of contact inhibition of 
proliferation 48,49, proliferation slow down. On a surface generating a faster 
migration, like 10H surfaces, cells tend to separate from the others faster and 
consequently proliferation is accelerated compared to surfaces with a slower 
migration rate like FLAT and 10L surfaces. Finally, after 8 days, surfaces 
functionalized with YIGSR showed a higher cell number compared to the 
respective surfaces functionalized with RGD, corroborating the higher potential 
of YIGSR to direct HUVEC behavior.  
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Figure IV.9: HUVECs proliferation on FLAT, patterned and/or functionalized CoCr surfaces at 2, 5 
and 8 days of cell culture obtained by Alamar blue assay. Bars designated with different letters 
belong to statistically different groups (p-value < 0.05). 
 
Overall, cell studies determined that peptide functionalization increased ECs 
adhesion and 10H DLIP patterning induced HUVECs alignment. Noteworthy, the 
synergy of these two effects on 10H-RGD and 10H-YIGSR surfaces accelerated 
HUVECs migration and proliferation. Blood circulating in the artery contains a low 
quantity of ECs. Consequently, the adhesion of ECs on the stent, which would 
be required to accelerate arterial regeneration, is limited, and, therefore, ECs 
migration from the surrounding healthy tissue plays a crucial role in the 
endothelialization process 50,51. In addition, previous studies demonstrated that 
DLIP patterned CoCr surfaces are anti-thrombogenic 1 and that CoCr alloy 
functionalized with YIGSR do not promote high levels of SMC adhesion 31. 
Therefore, CoCr alloys patterned by DLIP and functionalized with YIGSR seem 
to have a great potential to accelerate endothelium healing without generating 
platelet aggregation and SMC proliferation. 
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4. Conclusions 
In this work, we explored the possibility to increase specifically ECs adhesion, 
migration and proliferation on CoCr surfaces by combining topographical 
modification and biofunctionalization techniques. 
Flat CoCr surfaces were successfully modified by DLIP technique obtaining linear 
nanopatterned surfaces. These nanotopographies did not modify the corrosion 
properties and the surface charge of the CoCr alloy. 
To evaluate the combined effect of topographical modifications with 
biofunctionalization, RGD and YIGSR cell adhesive peptides were covalently 
immobilized to the surfaces through CPTES silanization. The coatings were 
characterized by physico-chemical methods and, moreover, showed stability 
against gamma radiation sterilization and ultrasonication.  
Cell studies indicated that RGD and YIGSR-coated surfaces induce a significant 
increase in ECs adhesion compared to non-functionalized surfaces. Moreover, 
10H pattern surfaces aligned the 80 % of adhered ECs while 10L did not affect 
cell alignment. When 10H patterned surfaces were functionalized, an accelerated 
ECs migration and proliferation was observed. Consequently, a positive synergy 
between surface linear patterning and functionalization was described. 
Therefore, DLIP patterned surfaces functionalized with RGD or YIGSR hold great 
potential to overcome clinical limitations of current stents by enhancing surface 
endothelialization. 
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1. Introduction 
Surface modifications onto biomaterials are a common approach to control 
biological response and could be classified in three main categories. First, 
topographical modifications that obtain specific nano- or micro- patterned 
surfaces can accelerate ECs migration 1,2. Second, physico-chemical 
modifications that generate suitable functional groups 3,4 and/or modulate surface 
energy 5,6 have demonstrated to modify ECs adhesion and spreading. Third, 
surface biofunctionalization by immobilizing specific biomolecules derived from 
extracellular matrix (ECM) proteins that have selectivity for ECs, could facilitate 
a cascade of biological events and eventually regenerate the damaged area with 
a functional endothelium 7–9. A strong covalent bonding between the implant and 
the biomolecules is desired to obtain a stable biofunctionalization 10. The most 
common chemical routes to obtain covalent bonding are the generation of 
functional groups at the surface, generally carboxyl (– COOH) or hydroxyl (– OH) 
groups, which react with a specific part of the biomolecule. Consequently, 
modifications that increase surface implant functional groups are of double 
interest since they could increase biocompatibility and enhance 
biofunctionalization. In that sense, surface treatments such as cold plasma 
treatment 11–13, ultraviolet irradiation 3, sodium hydroxide (NaOH) etching 14,15 or 
ozone irradiation 4 have shown to ameliorate surface functionalization. Also, 
enzymatic treatments have been proposed and successfully used for the surface 
modification of natural and synthetic polymers 9,16. For polyesters, such as PLLA, 
the hydrolysis of the ester bond by applying cutinase enzymes generate new 
hydroxyl and carboxyl groups onto the surface 9,17. 
Also, common stent fabrication processes do not allow to personalized stent 
shape. Consequently, in complex arteries stent implantation is impossible. 
3D-printing could be a strategy to produce each stent with a shape fully 
complementary to the target damaged artery. In particular, solvent-cast direct 
write technique have shown promising results to obtain complex 3D-printed 
shapes with PLLA inks 18. 
The aim of this work was to elaborate and characterize solvent-casted PLLA 
functionalized surfaces to enhance ECs adhesion and to assess the use of this 
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process and biomaterial to fabricate 3D-printed BRS. To assess biocompatibility, 
mechanical and degradation properties of the modified PLLA by solvent-casting 
it was evaluated cytotoxicity, crystallinity, molecular weight, Young modulus, 
ultimate tensile strength (UTS) and degradation rates. The effect of the different 
functionalization processes on PLLA properties was compared by characterizing 
surface roughness, surface wettability, films degradation, surface chemical 
properties and ECs adhesion. Finally, 3D-printed PLLA bioresorbable stent were 
obtained by the solvent-cast direct write technique to assess its feasibility. 
2. Materials and methods 
2.1. Materials 
Medical grade poly-L-lactic acid (PLLA) pellets (PURASORB PL65, 
Mw ≈ 1650000 g/mol) were obtained from Purac Biomaterials (Gorinchem, 
Netherlands). PLLA pellets were stored in a desiccator at room temperature (RT). 
Commercial PLLA films of 50 µm thick with a 37 % crystallinity (ME331050, 
Goodfellow, Coraopolis, USA) were used as reference. Samples made of this 
commercial films were coded as COM. 
Biodegradable PLLA peripheral stent REMEDY (Kyoto Medical Planning, Japan) 
was used in this study as positive control. Sample made of this commercial stent 
were coded as STNT. 
Humicola insolens cutinase enzyme (HiC) was kindly provided by Novozymes 
(Beijing, China) and used as received without any purification steps. 
Cellular experiments were conducted using HUVECs in the exact same 
conditions as in Chapter III (section 2.1.). 
2.2. PLLA films by solvent casting 
The PLLA films were manufactured by solvent-casting method 19. Previously, 
PLLA pellets were dried in an oven with controlled argon atmosphere at 80ºC for 
2 h. Then, PLLA pellets were dissolved in chloroform (Sigma-Aldrich, Germany) 
at a 3.6% weight versus volume (w/v) ratio. The dissolution took approximately 
48 h on an orbital shaker at RT. Once the PLLA was completely dissolved, the 
obtained paste was spread on a 150 mm diameter glass petri dish and 
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maintained 48 h under a chloroform saturated atmosphere to decrease the 
solvent evaporation rate. The studied surface was the one in contact with the 
glass petri dish. The obtained films had a thickness of approximately ≈ 150 µm. 
The obtained films were coded as SC. To increase crystallinity, the films were 
thermally treated at 80ºC during 12 h and coded as TT. Finally, to characterize 
the films, they were cut into 10 mm diameter discs.  
2.3. PLLA films surface activation 
Three different techniques of surface activation were applied to the fabricated TT 
films: 
 Cold plasma: Low pressure oxygen plasma in a 13.56 MHz radiofrequency 
reactor Diener Femto (Diener, Germany) was applied to TT films. At the center 
of the reactor an oxygen plasma was generated at 0.4 mbar pressure and 
100 W discharge power during 2 min. Details on the experimental setting can 
be found in a previous study 20. Obtained samples were coded as PL.  
 Chemical etching: TT films were chemically activated by submerging the 
samples in a 1 M sodium hydroxide (NaOH) solution under sonication during 
1 h at RT. After, treated samples were cleaned twice in distilled water during 
30 min to remove NaOH residues and samples were coded as NA. 
 Enzyme treatment: Previously to cutinase enzymes activation, TT films were 
prewashed as described in a previous study 21. Briefly, samples were 
submerged successively in L-1 Triton X100, Na2CO3 solution and double 
distilled water (ddH2O) for 30 min at 37°C and 130 rpm. After, cutinase 
enzymes were diluted in 100 mM Tris-HCl buffer with a pH=7 to obtain a 
10 µM enzyme solution. The films were immersed in 1 ml of the enzyme 
solution at 37ºC on an orbital shaker at 100 rpm during 24 h. Finally, films 
were cleaned with the previous protocol and obtained samples were coded 
as ENZ. 
2.4. PLLA films characterization 
Gel permeation chromatography (GPC) analyses were performed in an Agilent 
HPLC chromatograph 1260 Infinity series (Agilent Technologies, USA). 
Separation was carried in a Waters Styragel HR 5E column (USA) using CHCl3 
(HPLC grade) as eluent. Samples with concentration between 0.2 to 0.4 mg/ml 
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were analyzed. The used flow was of 0.4 ml/min and the amount of injected 
samples was 20 µl. Molecular weights were calculated after calibration with 
PMMA standards from Sigma-Aldrich (Germany), molecular weight calibration 
range was between 2.7 million to 2 thousands Dalton. Calculations were 
performed with the Chemstation Software (Agilent Technologies).  
Thermal analysis of the different PLLA samples were obtained by differential 
scanning calorimetry (DSC) with the instrument DSC 2920 Modulated (TA 
Instruments, USA) and following the ASTM D3418-03 standard 22. An empty 
aluminum pan was used as reference. 10 ng samples were run in a nitrogen 
atmosphere at 10ºC.min-1 heating ramp from 20 to 220ºC. The enthalpy of 
fusion (ΔHm) and the enthalpy of crystallization (ΔHcc) were obtained from the 
scan and used to calculate the percentage of crystallinity through the equation 
Xc = (ΔHm – ΔHcc) / ΔH0m where ΔH0m = 93 J/g is the enthalpy of fusion of a 
100% crystalline PLLA 23,24. 
Mechanical properties of PLLA films were determined by tensile test (DY 34, 
Adamel Lhomargy, France) according to the standard ASTM D882 – 02 25 using 
a 100 N load cell. First, PLLA films were cut following the standard ASTM D6287 
– 98 26 to obtain for each studied condition 5 samples of 150 mm length and 10 
mm width. The rate of grip separation was set to 15 mm/min and the curve load 
versus extension was recorded at RT. From the curve, Young modulus (E) and 
ultimate tensile strength (UTS) were obtained. 
To detect residues of chloroform in the PLLA films energy-dispersive X-ray 
spectroscopy (EDX) was performed with a Zeiss Neon40 FE-SEM microscope 
(Carl Zeiss NTS GmbH, Germany). Five measurements at 7 kV were done for 
each condition.  
The in vitro cytotoxicity of the PLLA films was evaluated by extracts using lactate 
dehydrogenase (LDH) enzyme measurement on HUVECs. The extracts were 
prepared according to ISO 10993-5 27 submerging the different fabricated PLLA 
films in complete cell medium for 3 days at 37ºC. Then, the extracts were serially 
diluted into five concentrations as 1/1; 1/2; 1/10; 1/100 and 1/1000 with fresh 
complete cell medium. Previously, PLLA films were sterilized in ethanol 70% 
during 30 min. Cells were seeded in a 96-well tissue polystyrene (TCPS) cell 
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culture plate at a seeding density of 15000 HUVECs/well and incubated normally 
for 24 h to allow attachment. After, cell medium was replaced by 200 µl of the 
different extract dissolutions. Complete fresh medium was used as negative 
control and complete fresh medium without cells was used as positive control. 
After 24h, alive HUVECs were quantified by measuring lactate dehydrogenase 
(LDH) enzyme. Briefly, cells were rinsed with PBS and lysed with 350 μl of 
mammalian protein extraction reagent (M-PER) (Thermo Scientific, Germany). 
The activity of LDH was determined by measuring the spectrophotometrical 
absorbance with a commercial LDH kit (Cytotoxicity Detection Kit, Roche 
Diagnostics, Mannheim, Germany) by a microplate reader (Infinite M200 PRO, 
Tecan Group Ltd., Switzerland) at 490 nm. According to the standard, cell viability 
was calculated with the following equation: 
cell viability = (Abssample - AbsC+/(AbsC- - AbsC+) where Abssample is the sample 
absorbance, AbsC+ is the positive control absorbance and AbsC- is the negative 
control absorbance. The results were shown by the percentages. Morphological 
signs of cell death were visible when the values of cell survival were below the 
level of 80% which was referred to as a threshold to define a cytotoxic response.   
2.5. Surface characterization 
Topography was evaluated with white light interferometry (WLI) (Optical 
interferometer Veeco Wyko 9300NT, Veeco Instruments, USA) in vertical 
scanning interferometry mode (VSI) at 100x magnification. Data analysis was 
performed with Wyko Vision 4.10 software (Veeco Instruments) to obtain the 
roughness parameter Ra (the arithmetic average height). Curvature and tilt were 
eliminated with a Gaussian filter. 
Water static contact angle was measured by the sessile drop method with a 
Contact Angle System OCA15plus (Dataphysics, Germany) 28. Milli-Q® water 
drops of 3 µl were deposited on the PLLA films and the contact angle between 
water and the different PLLA films was measured. An average of 15 drops were 
studied for each condition. The contact angle values were obtained after applying 
Laplace-Young fitting of the drop profile with SCA 20 software (Dataphysics).  
The chemical composition of PLLA films surface before and after topographical 
modification was analyzed by X-ray photoelectron spectroscopy (XPS) (SPECS 
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Surface NanoAnalysis GmbH, Berlin, Germany). The XPS spectra were obtained 
using an Mg anode XR50 operating at 150 W and a Phoibos 150 MCD-9 detector 
to record high resolution spectra at a pressure below 7.5 × 10−9 mbar. The 
elements present on the surface were evaluated by low-resolution survey 
spectra, whereas high-resolution of C 1s was recorded with detector pass energy 
fixed at 25 eV with 0.1 eV step at a pressure below 7.5 × 10-9 mbar. Casa XPS 
software (Version 2.3.16, Casa Software Ltd., Teignmouth, UK) was used to do 
fitting, peak integration of spectra and peaks deconvolution. Binding energies 
were referred to the C-C bond energy at 284.8 eV.  
2.6. PLLA films degradation 
To compare the rate of degradation of the different PLLA films compared to STNT 
an accelerated degradation assay was performed in alkaline solution 29–31. First, 
in order to have the same ratio surface/volume for each condition, all the PLLA 
films were cut in fibers with the same diameter as STNT stent strut (≈ 150 µm). 
All samples (COM, STNT, SC, TT, PL, NA and ENZ) were dried in an argon 
atmosphere oven at 48ºC during 2 h and weighted with a Sartorius Quintix35-1S 
laboratory balance (Göttingen, Germany). Next, all samples were placed at 37ºC 
in a solution of 0.1 M NaOH. At 2, 4, 7 and 10 days samples were weighted in 
order to calculate the mass loss. Also, initial and final samples surface were 
observed by scanning electron microscopy (SEM) with a Zeiss Neon40 FE-SEM 
microscope (Carl Zeiss NTS GmbH, Germany). For each sample, five images 
were taken at a working distance of 6 mm and a potential of 5 kV. Finally, samples 
topography was characterized by WLI, as previously described (section 2.7), to 
evaluate changes between final (Raf) and initial (Rai) mean roughness, the ratio 
Raf/Rai was calculated. 
2.7. HUVECs adhesion 
Cell adhesion assay was performed by seeding HUVEC at a density of 5x104 
cells/sample with serum-free medium and cellular analyses were carried out at 
12 h after cell seeding. The different PLLA samples were previously sterilized in 
ethanol 70% during 15 min at RT. To quantify the density of adhered HUVECs 
after 12 h, the release of LDH enzyme was measured as previously described for 
the indirect cytotoxicity assay (section 2.6). In parallel, cell adhesion was 
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observed by scanning electron microscopy (Zeiss Neon40 FE-SEM microscope, 
Carl Zeiss NTS GmbH, Germany). To that end, HUVECs were fixed with 
glutaraldehyde (G400-4, Sigma-Aldrich), dehydrated by immersion in different 
solutions of increasing ethanol % and, finally, sputtered with gold-palladium 
coating. For each sample, ten images were taken at a working distance of 6 mm 
and a potential of 5 kV. The percentage of area covered by HUVEC was 
determined using FIJI ImageJ software 32. 
2.8. 3D-printed BRS obtained by solvent-cast direct write technique 
The 3D-printed PLLA stent were obtained using a fused deposition modelling 3D 
printer (BCN 3D+, BCN 3D technologies, Barcelona, Spain). The printer was 
modified to solvent cast PLLA inks though a syringe micronozzle with a 250 µm 
inner diameter (Nordson®, USA). PLLA inks were prepared as described in 
section 2.2 and printing was realized at a (0.4) mm3.s-1 flux and 4 mm.s-1 robot 
velocity. Also, the printer Y axe was modified by introducing a carbon fiber 
rotating mandrel in order to print cylindrical structures. The BRS shape was adjust 
from the Igaki-Tamai stent (Kyoto Medical Planning, Japan) design structure and 
dimensions were 5 mm diameter and 20 mm length.  
2.9. Statistical analysis 
The experimental data collected in this study are reported as mean ± standard 
deviation. A one way analysis of variance (ANOVA) was used to determine the 
statistical significance of difference at p<0.05 (Minitab 16.2.2 Statistical Software, 
Minitab Inc.). Unless otherwise specified, all experiments were performed with at 
least n=3 samples for each specimen group. In addition, each experiment was 
repeated at least twice. 
 
3. Results and discussion 
The aim of this study was to evaluate solvent-casted and functionalized PLLA to 
enhance ECs adhesion and its use as biomaterial for stent fabrication by 3D 
printing. To this end, the effect of solvent casting and functionalization processes 
onto PLLA biocompatibility, degradation and mechanical properties were 
evaluated. In parallel, surface functional groups density was measured to 
compare the effect of NaOH, oxygen plasma and cutinase enzymes activation 
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surface treatments. Finally, as a proof of concept, 3D-printed PLLA stent were 
obtained by the solvent-cast direct write technique. 
3.1. PLLA film properties 
To evaluate potential cytotoxic effects of the solvent employed for the synthesis 
of the PLLA films and/or the different activation treatments, an indirect cytotoxicity 
assay was performed (Table V.1). The standard specifies that a material is 
cytotoxic if the percentage of cell survival is inferior to 80 %. The results indicated 
that SC samples were cytotoxic but thermal treatment increased cell viability 
reaching values of non-cytoxicity, higher than 92%, as observed for TT samples. 
Activation treatments of oxygen plasma and enzyme treatment did not affect 
cytotoxicity of TT films. But, NA samples presented cytotoxicity in some cases 
probably due to NaOH residues in the obtained films.  
The presence of chlorine residues from solvent casting fabrication was verified 
by EDS (Table V.2). COM and SC were the only films presenting Cl residues. As 
chloroform toxicity is well known 33,34, the cytotoxicity of SC observed previously 
was probably due to this residual chloroform in the film. Also, the absence of Cl 
in TT films suggested that thermal treatment helped PLLA solvent-cast films to 
be biocompatible by evaporating chloroform residues. 
 
Table V.1: Cell viability on the different solvent-cast PLLA films. Results correspond to the 
percentage of alive cells after an indirect cytotoxicity assay. 1/1, 1/2, 1/10, 1/100, 1/1000 are 
different dilutions of the medium which have been previously in contact 72 h with the respective 
PLLA films. In red it is indicated cell cytotoxic surfaces.  
 Cell viability (%) 
Sample 1/1 1/2 1/10 1/100 1/1000 
SC 45 ± 26 70 ± 13 67 ± 12 79 ± 16 94 ± 12 
TT 95 ± 3 95 ± 4 92 ± 4 102 ± 15 96 ± 7 
PL 101 ± 4 113 ± 6 122 ± 16 116 ± 12 113 ± 18 
NA 95 ± 15 92 ± 19 76 ± 12 86 ± 7 123 ± 13 
ENZ 98 ± 11 112 ± 24 111 ± 25 112 ± 12 121 ± 21 
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PLLA PL65 from Purac was chosen for its particularly high molecular weight and 
crystallinity in order to fabricate PLLA films with mechanical and degradation 
properties similar to actual PLLA BRS. Table V.2 shows the results obtained of 
GPC and DSC techniques since solvent casting and activation treatments could 
reduce molecular weight and crystallinity. Generally, all the processed films 
presented Mw values in the same range, from 0,89 up to 0,98 x 106 g/mol. But 
STNT presented a Mw five times lower than SC films. SC and TT films presented 
statistically similar molecular weight, respectively 
0.95 ± 0.04 and 0.98 ± 0.03 106 g/mol. Thus, thermal treatment did not 
significantly affect PLLA chain: nor by generating polymerization, neither by 
degrading PLLA. The three functionalizing treatments could break PLLA chains 
and, consequently, reduce PLLA films Mw. No significant changes were observed 
after plasma activation (PL) and enzyme hydrolysis (ENZ) suggesting that these 
processes work at the outermost surface layer. On the contrary, NA showed a 
significant 10 % reduction of the molecular weight compared to TT meaning 
NaOH etching affects to a deeper surface layer compared to the other 
treatments. 
A huge difference in crystallinity is observed between STNT, and the processed 
films. COM and STNT presented respectively a percentage of crystallinity of 
18.7 ± 2.3 and 50.5 ± 2.7 %. SC presented a percentage of crystallinity 3 times 
lower than the PL65 pellet employed for this synthesis. This decrease of 
crystallinity due to solvent casting process has already been reported 35 and is 
mainly associated to the fast chloroform evaporation not allowing polymer 
macromolecules to diffuse to the crystal growth front and overcome the energy 
barrier of deposition 36. As expected, thermal treatment helped to increase 
crystallinity in TT due to chain reorganization 30,37. The three activation treatments 
did not affect crystallinity. 
A tensile test was done on SC and TT to evaluate the effect of the thermal 
treatment on mechanical properties. TT films presented a 5 times higher Young 
modulus (2.85 ± 0.27 GPa) and 2 times higher UTS (62.2 ± 5.7 MPa) compared 
to SC films (E: 0.53 ± 0.10 GPa and UTS: 28.9 ± 2.6 MPa). The increased 
mechanical properties on TT films are related to the increased crystallinity 38 and 
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the evaporation of solvent residues produced by the thermal treatment. Indeed, 
solvent residues act as a plasticizer and reduce dramatically tensile strength 35. 
The Young modulus and UTS of TT films are in the upper range of the mechanical 
properties reported for PLLA family 39. Consequently, the obtained solvent-cast 
PLLA would probably respond properly to the mechanical stress occurring during 
stent implantation. This could be of great interest to obtain 3D printed PLLA 
biodegradable stent by solvent casting direct write technique 18. 
Table V.2: Bulk properties of COM, STNT and all the different solvent-cast films: presence of 
Cl residues, Mw = molecular weight obtained by HPLC and % of crystallinity following DSC. 
Sample Cl residues 
Mw  
(106 g/mol) 
% cristallinity 
COM Yes 0.16 ± 0.00 18.7 ± 2.3 
STNT No 0.19 ± 0.00 50.5 ± 2.7 
SC Yes 0.95 ± 0.04 12.5 ± 3.1 
TT No 0.98 ± 0.03 26.6 ± 2.7 
PL No 0.95 ± 0.01 25.1 ± 1.7 
NA No 0.89 ± 0.01 24.2 ± 2.7 
ENZ No 0.97 ± 0.02 25.8 ± 0.4 
 
3.2. Surface characterization 
Surface roughness modifications due to activation treatments were characterized 
by white light interferometry (WLI) (Figure V.1). SC surfaces obtained the lowest 
value of Ra, but it was statistically equal to TT, PL and ENZ suggesting these 
three treatments had a negligible effect on the surface roughness. Contrary, the 
effect of NaOH treatment was more aggressive and modified surface roughness 
parameters by doubling the parameter Ra compared to the other films. In addition 
to the fact that NaOH treatment also decreased PLLA molecular weight, it is 
suggested that alkaline activation process was a more aggressive treatment than 
plasma and enzyme treatment, affecting few microns depth from the surface of 
PLLA films.  
Wettability of the different fabricated PLLA films was characterized by water 
contact angle (Figure V.1). Water contact angle on SC films is 10º higher than 
COM (70.0 ± 0.7º) as reported in a previous study 40. This difference could be 
explained by the higher Mw of the PLLA used to fabricate SC films, inducing a 
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lower density of surface functional groups and consequently a lower hydrophilicity 
13. Wettability evaluation revealed also that thermal treatment increased 
significantly water contact angle compared to SC. NaOH etching did not change 
the wettability as NA presented a water contact angle of 84.2 ± 4.3º with no-
statistical difference when compared to TT. On the other hand, plasma and 
enzyme activation treatments reduced significantly water contact angle, obtaining 
values ≈ 20º and ≈ 25º, respectively, lower than TT. Other authors have already 
reported the increase in hydrophilicity after plasma treatment 13,41,42 and 
enzymatic hydrolysis 21,42,43 on PLA, or other polyesters. This is usually attributed 
to the creation of new surface functional groups 13,41,42. 
Figure V.1: Surface properties of all the solvent-cast PLLA films. (A) Roughness Ra (arithmetic 
roughness average) calculated from WLI images. (B) Water contact angle on the different 
PLLA films. Columns marked with different letters belong to statistically different groups 
(p-value < 0.05). 
 
Surface chemical composition of TT and activated films is shown in Table V.3. 
XPS analysis revealed the presence of C 1s, O 1s, N 1s and Na 1s. The atomic 
percentage of O 1s increased while C 1s decreased for all activated surfaces 
compared to TT films. Consequently, O/C ratio was higher on activated surfaces 
(> 0.64) compared to TT (0.61). The increase confirmed the incorporation of O 
1s on the PLLA films surfaces to form functional group. O/C ratio was statistically 
higher on PL and ENZ films, 0.75 and 0.97, respectively compared to NA (0.64), 
suggesting a higher efficiency of plasma and enzyme to create functional groups. 
Also, presence of N 1s was observed in small quantities on PL and ENZ films 0.8 
± 0.1 and 0.5 ± 0.1 %, respectively. For PL samples, the detection of N 1s was 
associated with air contaminations in the plasma chamber. But for ENZ samples 
it was associated to residues of cutinase, as cutinase contains nitrogen 44. Finally, 
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NA films showed the presence of Na 1s at a low quantity (0.5 ± 0.1 %), these 
residues of NaOH could explain the cytotoxicity observed on these films. 
 
Table V.3: Analysis of the atomic composition percentage at the TT, PL, NA and ENZ surfaces by 
XPS. Values of O 1s, C 1s, N 1s, Na 1s and ratio between O/C were obtained from the XPS survey 
spectra. Values of the relative chemical carbon bonds were obtained from the deconvolution of 
C 1s peaks. 
 
Elemental composition (atomic %) 
 
Relative chemical carbon bonds 
(%) 
O 1s C 1s N 1s Na 1s O/C 
 284.7 eV 286.6 eV 288.8 eV 
C-C, C-H C-O O=C-O 
TT 37.7 ± 0.5 62.3 ± 0.5 0.0 ± 0.0 0.0 ± 0.0 0.61  42.1 ± 0.9 28.7 ± 0.7 29.2 ± 0.6 
PL 42.3 ± 0.3 56.8 ± 0.4 0.8 ± 0.1 0.0 ± 0.0 0.75  30.4 ± 0.2 32.8 ± 0.1 36.9 ± 0.1 
NA 39.0 ± 0.3 60.9 ± 0.2 0.0 ± 0.0 0.2 ± 0.0 0.64  34.6 ± 0.9 34.7 ± 1.4 30.7 ± 1.0 
ENZ 49.0 ± 0.2 50.4 ± 0.2 0.5 ± 0.1 0.0 ± 0.0 0.97  31.1 ± 0.4 32.4 ± 0.6 36.6 ± 0.4 
 
Figure V.2: High-resolution spectra of C 1s obtained by XPS for (A) TT, (B) PL, (C) NA and 
(D) ENZ surfaces. Dashed lines represent the ﬁtting components and solid lines the sum of these 
components. 
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The deconvolution of the high-resolution C 1s peak has been applied for TT and 
activated samples (Table V.3 and Figure V.2). On all surfaces, C 1s peak was 
composed of three peaks corresponding to: (1) C – C and C – H bonds at 
284.7 eV; (2) C – O bonds at 286.6 eV and; (3) O = C – O bonds at 288.8 eV 42. 
All activated surfaces presented a significantly higher atomic percentage of 
O = C - O bonds (> 30.7 ± 1.0 %) than TT films (29.2 ± 0.6 %) meaning all three 
activation treatments created – COOH functional groups. Plasma and enzyme 
treatments presented 36.9 ± 0.1 and 36.6 ± 0.4 % of O = C – O bonds, 
respectively, meaning a higher amount of carboxyl group were created on these 
surfaces than on alkaline surface (30.7 ± 1.0 %). When hydrolyzing an ester 
bond, a single - COOH and a single - OH group are created 45. As NaOH solution 
and enzyme act on PLLA only by ester bond hydrolysis, on NA and ENZ surfaces 
the increase of hydroxyl group is proportional to the increase of the generated 
carboxyl groups. Plasma treatment do not act only by hydrolysis, there is also a 
formation of functional group in surface with the oxygen excited species present 
in the plasma. The fact that O/C ratio was inferior on PL compared to ENZ and 
that PL and ENZ presented similar percentage of carboxyl group suggested that 
PL had less hydroxyl groups than ENZ. 
 The higher density of functional group on PL and ENZ compared to NA samples 
is coherent with the higher decrease of wettability observed after plasma or 
enzyme hydrolysis compared to alkaline hydrolysis, suggesting plasma and 
enzyme hydrolysis presented the best efficiency to create functional group in 
order to biofunctionalized a surface or to improve implant biological response. 
3.3. Degradation of PLLA films 
BRS stents are expected to maintain their radial strength at least during the 6 
months post implantation, the stent material should degrade without losing 
mechanical properties during this period of time 46,47. High Mw PLLA are expected 
to have a slow degradation rate compared to low Mw polyester 48. An accelerated 
degradation assay was conducted in conditions similar to previous works 29–31,49. 
The films were immersed in a 0.1 M NaOH solution during 10 days in order to 
evaluate the effect of solvent-casting, thermal and activation treatments on 
degradation of high Mw PLLA by measuring the percentage of mass 
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loss (Figure V.3). Moreover, surface SEM images and roughness of the studied 
surfaces before and after the degradation assay are shown in Figure V.4. 
As expected, all samples presented a linear decrease of the percentage of mass 
loss with time. This behaviour, was already described by D. Cam et al. 29 in 
alkaline solution and it is totally different to the sigmoidal degradation pattern 
observed for PLLA in saline and buffered solutions or in body conditions related 
by Middleton et al. 47. COM and SC films clearly presented statistically faster 
degradation rates compared to other surfaces. For example SC and COM mass 
loss after 10 days was higher than 45 %; whereas, all the other films had a mass 
loss lower than 30 %. According to literature 29, as degradation occurs first in the 
amorphous part, the faster degradation on SC and COM could be explained by 
the lower crystallinity of these films. In addition, on one hand, PL and ENZ films 
presented a mass loss statistically equal to TT films at each time point, 
suggesting that the studied activation treatments do not affect PLLA degradation 
since they act at the outermost layers of the surface. On the other hand, NA films 
presented a slightly faster degradation rate than TT films resulting probably from 
the greater surface in contact with the NaOH solution, due to the higher 
roughness. Finally, TT, PL and ENZ films showed a degradation rate statistically 
similar to Remedy stent (STNT) degradation rate. Associating this result with the 
high mechanical properties of TT films observed and the non-modified 
crystallinity and Mw after plasma and enzyme hydrolysis, it can be concluded that 
TT, PL and ENZ films are suitable for stent fabrication. 
According to the SEM images, a clear degradation of the surface and an 
increased roughness can be observed for all samples, except for STNT surface. 
The faster degradation observed by mass loss on SC and COM compared to the 
other samples was confirmed by a higher surface deterioration, and an increase 
of Ra by a factor of 5.51 and 11.65, respectively. Surfaces with thermal treatment 
presented a lower surface degradation and Ra was increased by a factor 1.86. 
Thus, confirming that the increase of crystallinity made the PLLA more resistant 
to degradation. NaOH, plasma and enzyme activated surfaces had a surface 
degradation similar to TT, confirming also that the studied activation treatments 
did not affect PLLA degradation.  
Chapter V 
126 
 
Figure V.3: % mass loss evolution during alkaline accelerated degradation assay on COM, STNT 
and all solvent-cast PLLA films. Assay was done in a 0.1 M NaOH solution during 10 days. 
 
Figure V.4: SEM images and roughness ratio Raf/Rai of COM, STNT and all solvent-cast PLLA films 
before and after alkaline accelerated degradation assay. Assay was done in a 0.1 M NaOH 
solution during 10 days. Scale bar = 50 µm.  Roughness was obtained from WLI. STNT roughness 
could not be characterized for geometrical reasons.   
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3.4. HUVECs adhesion 
In order to biologically characterize the effect of plasma, NaOH and enzyme 
hydrolysis of PLLA solvent-cast films, it was evaluated HUVECs adhesion after 
12 h of cell culture. Cell number was slightly higher on NA films 
(25787 ± 2288 cells/cm2) compared to TT surfaces (21297 ± 1528 cell/cm2) 
(Figure V.5A). Whereas, PL and ENZ films presented statistically higher number 
of HUVECs, 36958 ± 2967 and 33541 ± 4434 cells/cm2 respectively, compared 
to TT and NA samples. SEM images confirmed visually the higher cell density on 
activated surfaces and showed a higher spreading on these surfaces compared 
to TT films (Figure V.6). In particular, cell close-up images of TT surfaces showed 
round HUVECs, non-expanded, showing an initial adhesion stage with many 
extended filopodia. On the contrary, HUVECs on PL, NA and ENZ films were flat 
and extended. This higher cell number and spreading on activated surfaces 
induced a percentage of area occupied by HUVECs at least 4 times higher 
compared to TT samples (Figure V.5B). Plasma and enzyme activation had the 
highest values with 66.0 ± 11.5 and 58.7 ± 3.9 %, respectively. Surface 
characteristics such as wettability and functional group density evolved 
proportionally with HUVECs adhesion on the three functionalized surfaces, 
confirming the relationship between higher functional group density, hidrophilicity 
and increased cell adhesion. The reason for this correlation could be attributed 
to a higher protein adsorption on hydrophilic surfaces, as reported previously 50,51.  
In summary, concerning the effect of the different activation treatments applied 
to PLLA surfaces on cell response we found that, on the one hand, plasma and 
enzyme activation increased PLLA biocompatibility by improving HUVECs 
adhesion and also, created a higher density of surface functional groups that can 
be used to covalently immobilize biomolecules. On the other hand, sodium 
hydroxide activation showed a lower density of activated functional groups onto 
the surface compared to other activation treatments and HUVECs adhesion 
slightly increased compared to control. Moreover, NaOH activation increased 
PLLA films roughness which could dramatically induce a higher platelet adhesion 
and promote thrombus formation when using this surface for cardiovascular 
applications 52,53. 
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Figure V.5: HUVECs adhesion and spreading on TT and activated films after 12 h of cell culture. 
(A) Cell number quantified by LDH enzymatic assay. (B) % of area occupied by HUVEC obtained 
after SEM images analysis. Images were analysed with FIJI software. Columns with different 
letters belong to statistically different groups (p-value < 0.05). 
 
 
Figure V.6: SEM images of HUVECs adhesion and spreading on TT and activated surfaces after 
12h of incubation. 
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3.5. BRS obtained by solvent-cast direct write technique 
Solvent-cast high molecular weight PLLA activated with plasma or enzymes 
presented appropriate cristallinity, molecular weight, degradation rate and 
enhanced ECs response which makes it a biomaterial suitable to be used for 
BRS fabrication. As a proof of concept, PLLA BRS stent were fabricated by 
solvent-cast direct write technique to assess its feasibility. The 3D-printer was 
modified with a rotating mandrel and it was successfully fabricated seamless BRS 
of 5 mm diameter and 20 mm length (Figure V.7). The stents presented 
homogeneous wire diameter around 150 µm and the junctions between wires 
were welded properly. 
 
Figure V.7: PLLA BRS obtained by solvent-cast direct write technique. Upper image: General 
image of PLLA BRS by optical microscopy. Lower images: Detailed optical microscopy images of 
the PLLA BRS wires. 
 
4. Conclusions 
In this work, we evaluate the potential of solvent-cast PLLA functionalized by 
oxygen plasma, NaOH solution or cutinaze enzyme to enhance ECs adhesion 
and to be used for 3D-printed BRS fabrication. After thermal treatment, 
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solvent-cast PLLA presented full biocompatibility, high mechanical properties and 
degradation rates similar to the commercial Remedy BRS. Moreover, plasma and 
enzyme functionalization that did not affect the bulk properties of the PLLA films, 
increased significantly the hydrophilicity, the density of surface functional groups 
and the ECs adhesion and spreading. On the contrary, NaOH hydrolysis was not 
fully biocompatible and was proven to be less efficient than plasma and enzymes 
in terms of creating functional groups and improving ECs response. Finally, 
solvent-cast direct write technique was used to print on a rotating mandrel and 
3D-printed PLLA BRS seamless were obtained. Consequently, the combined use 
of the solvent-cast direct write technique and plasma or enzyme functionalization 
holds great potential to fabricate 3D-printed PLLA BRS with the capacity to 
accelerate the surface endothelialization. 
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Chapter VI: General conclusions  
  
Stents implantation has been a revolutionary advance in the treatment of 
atherosclerosis. However, none of the three stent generations, BMS, DES and 
BRS, achieved to avoid ISR and LST complications after coronary intervention. 
To overcome these drawbacks and to obtain a functional artery after coronary 
stent implantation, it is decisive to accelerate stent surface endothelialization and, 
if possible, without the use of antiproliferative drugs that generally delay the 
formation of a healthy endothelium.  
Different strategies, based in surface modification, were explored in this thesis in 
order to control ECs and platelet response on CoCr alloy and PLLA surfaces for 
cardiovascular applications. The results displayed and analyzed in the previous 
chapters, which are summarized and highlighted in the following conclusions, 
expanded our comprehension in the field that could lead to the fabrication and 
design of stents with enhanced endothelialization and reduced platelet adhesion, 
ameliorating ISR and LST rates of actual commercial stents. 
 
 Topography modification of CoCr alloy surfaces: 
CoCr alloy was modified and linear patterned surfaces with periodicities between 
3 and 32 µm and, depths around 20 and 800 nm were obtained by DLIP 
technique. Surface modification did not modify the corrosion properties and the 
surface charge of CoCr alloy. Low depth patterned surfaces presented negligible 
topographical modification and they did not show significant effect on ECs 
response compared to smooth CoCr surfaces. Otherwise, the significant 
topographical modifications of high depth patterned surfaces induced ECs 
elongation, alignment and migration following the pattern direction.  
As a consequence of the high temperatures generated during DLIP, there was a 
transformation of the crystalline oxide layer into a thicker and homogeneous 
amorphous oxide layer with lower wettability. All patterned surfaces decreased 
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platelet adhesion and aggregation, indicating that the oxide layer structure 
transformation affected surface thrombogenicity. 
 
 
 Topography modification and biofunctionalization of CoCr alloy surfaces: 
The combination of topography and biochemical features as a strategy to 
accelerate and increase ECs adhesion and migration, was successfully achieved. 
Smooth and 10 µm periodicity patterned CoCr alloy surfaces were covalently 
biofunctionalized with RGD and YIGSR cell adhesive peptides through CPTES 
silanization. Peptide functionalization and, particularly YIGSR, increased the 
number of adhered ECs compared to non-functionalized surfaces. The majority 
of the coating peptide is stable when subjected to either gamma radiation 
sterilization or ultrasound sonication.  
The combination of high-depth patterned and functionalized surfaces accelerated 
ECs migration and proliferation. The positive synergy between linear patterning 
and biofunctionalization makes this approach of great potential to accelerate 
endothelium healing without generating platelets adhesion and aggregation. 
 
 
 Functionalization of solvent-cast PLLA films: 
Biocompatible solvent-cast PLLA surfaces with mechanical properties and 
degradation rates similar to the commercial Remedy BRS were obtained after 
thermal treatment. Surface functionalization with oxygen plasma and cutinase 
enzyme increased significantly the hydrophilicity, the density of surface functional 
groups and the ECs adhesion and spreading without affecting the bulk 
mechanical and crystallinity properties of PLLA films. Consequently, plasma and 
cutinase enzyme PLLA hydrolysis could be used as a previous step for covalent 
immobilization of biomolecules or, directly, as a functionalization step to improve 
ECs response.  
3D-printed PLLA BRS seamless were obtained by solvent-cast direct writing on 
a rotating mandrel. Consequently, the combined use of the solvent-cast direct 
write technique and plasma or cutinase enzyme functionalization could be a 
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potential strategy to fabricate 3D-printed PLLA BRSs with the capacity to 
accelerate the surface endothelialization. 
